Postprocedural disorders of nervous system

G6_POSTOPNEURO

nervous system disease: A non-neoplastic or neoplastic disorder that affects the brain, spinal cord, or peripheral nerves.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — G97 Hospital discharge: ICD-9 — 3490\|9970 Cause of death: ICD-10 — G97 Cause of death: ICD-9 — 3490\|9970 2 out of 7 registries used, show all original rules.	3433
4. Check minimum number of events None	3433
5. Include endpoints None	3433
6. Filter based on genotype QC (FinnGen only)	3125

Control definitions (FinnGen only)

Control exclude: G6_OTHNEU

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: G90-G99
Name in latin: Morbositates systematis nervosi post interventiones non alibi classificatae

NAME	G6_POSTOPNEURO
CONTROL_EXCLUDE	G6_OTHNEU
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	G97
HD_ICD_9	3490\|9970
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	G97
COD_ICD_9	3490\|9970
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Postprocedural disorders of nervous system based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	17984	12561	5331
Only index persons	17409	12324	5085
Unadjusted period prevalence (%)
Whole population	0.30	0.36	0.15
Only index persons	0.38	0.45	0.19
Median age at first event (years)
Whole population	34.51	34.74	33.96
Only index persons	34.38	34.68	33.66

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3125	2426	699
Unadjusted period prevalence (%)	0.74	0.86	0.32
Median age at first event (years)	37.15	36.18	40.49

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3228: Matched controls
32280

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

G97.0

ICD-10 Finland

Cerebrospinal fluid leak from spinal puncture

16384.0

307.7

2513

TAB22

NOMESCO Finland

Stoppin epidural fluid escape with coagulated blood

179.1

307.7

1205

107

R51.80

ICD-10 Finland

Headache

5.1

307.7

1331

3914

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

6.5

307.7

692

1291

G97.1

ICD-10 Finland

Other reaction to spinal and lumbar puncture

+∞

307.7

362

TAB00

NOMESCO Finland

Lumbar puncture

18.0

307.7

865

642

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

5.0

250.0

614

1435

3490A

ICD-9 Finland

Other and unspecified disorders of the nervous system, Reaction to spinal or lumbar puncture

+∞

237.5

225

R20.2

ICD-10 Finland

Paraesthesia of skin

4.9

226.5

577

1384

AA1AD

NOMESCO Finland

CT of head and brain

3.4

210.4

1005

3751

G35

ICD-10 Finland

Multiple sclerosis

9.3

188.9

234

268

N03AX12

ATC

[U] gabapentin; oral

3.5

178.0

777

2710

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

4.0

169.4

555

1594

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

17.8

161.6

132

109

Kela drug reimbursment

Multiple sclerosis

9.8

160.2

190

205

G44.2

ICD-10 Finland

Tension-type headache

3.0

146.2

824

3304

N03AX16

ATC

[U] pregabalin

2.8

141.8

939

4099

157

Kela drug reimbursment

Dimethyl fumarate, glatiramer acetate, interferon beta and teriflunomid (Multiple sclerosis)

9.8

140.2

165

176

303

Kela drug reimbursment

Dimethyl fumarate, interferon beta, glatiramer acetate and teriflunomid (Multiple sclerosis)

9.4

134.6

164

183

N02AX02

ATC

tramadol; systemic, rectal

2.5

133.4

1533

8678

R42

ICD-10 Finland

Dizziness and giddiness

2.7

127.8

889

3952

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

4.4

125.4

339

837

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.4

123.0

1631

9728

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

4.3

117.3

324

812

N06AX21

ATC

duloxetine; oral

2.9

116.6

641

2505

G43.9

ICD-10 Finland

Migraine, unspecified

3.3

114.3

498

1701

ZXD05

NOMESCO Finland

Urgent procedure

2.3

112.9

1263

6936

H46

ICD-10 Finland

Optic neuritis

9.5

108.3

130

142

G37.9

ICD-10 Finland

Demyelinating disease of central nervous system, unspecified

10.7

106.5

117

113

Z01.0

ICD-10 Finland

Examination of eyes and vision

2.7

102.3

702

3061

G97.8

ICD-10 Finland

Other postprocedural disorders of nervous system

487.0

95.9

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

3.0

92.9

468

1728

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.9

91.6

488

1858

XA800

NOMESCO Finland

Neuropsychological investigation

4.5

91.1

236

561

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

8.4

90.4

119

146

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

2.3

88.7

829

4139

L03AX13

ATC

glatiramer acetate; parenteral

12.0

87.8

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

3.1

86.9

401

1406

N06AA09

ATC

amitriptyline; systemic

3.2

86.1

371

1249

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

4.9

83.7

192

413

M79.6

ICD-10 Finland

Pain in limb

2.0

82.0

1660

11087

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

5.5

81.2

160

301

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.1

79.8

1187

7079

M03BX01

ATC

baclofen; systemic

6.3

79.7

137

226

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.7

77.2

465

1879

N03AX11

ATC

topiramate; oral

4.5

76.0

194

455

R51

ICD-10 Finland

Headache

3.0

74.5

363

1308

N86

ICPC

Multiple sclerosis

10.5

74.0

2309

FHL

Other measure in this category

40.5

72.3

H02AB06

ATC

prednisolone; systemic

1.9

71.5

1586

10756

A02BC05

ATC

esomeprazole; systemic

2.0

71.4

1383

8962

N06AX16

ATC

venlafaxine; oral

2.3

71.4

691

3465

Z01.8

ICD-10 Finland

Other specified special examinations

2.1

71.3

852

4645

A02BC02

ATC

pantoprazole; systemic

2.0

71.1

2222

16892

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

3.2

70.1

301

1007

N02BF01

ATC

gabapentin; oral

2.6

69.1

445

1854

H53.1

ICD-10 Finland

Subjective visual disturbances

3.1

68.8

321

1127

M03BX02

ATC

tizanidine; oral

2.0

68.3

2260

17393

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.9

68.2

1319

8506

M25.5

ICD-10 Finland

Pain in joint

1.9

67.8

1333

8638

H53.2

ICD-10 Finland

Diplopia

4.8

67.3

155

334

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

2.3

67.0

571

2706

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

5.5

66.9

131

245

L03AB07

ATC

interferon beta-1a; parenteral

8.8

66.0

M01AE03

ATC

ketoprofen; systemic, rectal

1.9

65.6

1144

7106

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.0

64.5

892

5106

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

2.8

64.4

361

1400

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.4

64.4

514

2364

M54.5

ICD-10 Finland

Low back pain

1.9

64.3

1426

9563

G93.2

ICD-10 Finland

Benign intracranial hypertension

+∞

62.7

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.9

62.7

1505

10324

M54.4

ICD-10 Finland

Lumbago with sciatica

2.1

62.4

748

4057

UKC02

NOMESCO Finland

Cystoscopy

2.6

62.1

389

1595

164

Kela drug reimbursment

Fingolimod

11.4

61.4

N06AX11

ATC

mirtazapine; oral

1.9

61.0

1227

7940

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

5.4

58.2

117

224

TPH04

NOMESCO Finland

Cathetrisation of vein

2.1

58.2

714

3894

R07.4

ICD-10 Finland

Chest pain, unspecified

2.0

57.6

843

4893

G97.9

ICD-10 Finland

Postprocedural disorder of nervous system, unspecified

+∞

57.5

R52.2

ICD-10 Finland

Other chronic pain

3.6

57.2

194

558

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.0

57.1

726

4007

N02BE01

ATC

paracetamol; systemic, rectal

2.6

56.4

2931

25516

XCK00

NOMESCO Finland

Perimetry

3.6

56.2

196

574

N03AE01

ATC

clonazepam; systemic

3.2

55.8

237

786

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

5.3

55.6

114

222

G43.3

ICD-10 Finland

Complicated migraine

4.2

55.3

150

368

XKD00

NOMESCO Finland

Uroflowmetry

2.8

55.1

292

1096

R53

ICD-10 Finland

Malaise and fatigue

1.9

55.0

980

6058

M03BC01

ATC

orphenadrine (citrate); systemic

1.9

52.1

890

5411

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.5

52.1

356

1517

A03FA01

ATC

metoclopramide; systemic, rectal

1.9

52.1

774

4495

L04AA27

ATC

[U] fingolimod

13.4

52.0

A02BC03

ATC

lansoprazole; oral

1.9

51.9

855

5136

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

7.6

51.8

100

R03AC02

ATC

salbutamol; inhalant

1.8

51.5

1965

15116

G97.2

ICD-10 Finland

Intracranial hypotension following ventricular shunting

+∞

51.2

S01EC01

ATC

acetazolamide; systemic

6.1

51.1

152

R1250

NOMESCO Finland

Evaluation of functional capability

4.7

51.0

120

263

M79.0

ICD-10 Finland

Rheumatism, unspecified

3.8

50.5

161

444

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

8.8

50.0

R50.9

ICD-10 Finland

Fever, unspecified

2.1

49.8

561

2947

N03AX09

ATC

lamotrigine; oral

2.7

49.4

278

1076

M79.7

ICD-10 Finland

Fibromyalgia

3.2

49.2

205

671

353

Kela drug reimbursment

Cladribine and fingolimod

10.5

49.1

N01

ICPC

Headache

2.1

48.9

578

3088

J01AA02

ATC

doxycycline; systemic

1.9

48.6

2477

20566

R52.9

ICD-10 Finland

Pain, unspecified

2.3

48.4

411

1927

R06.0

ICD-10 Finland

Dyspnoea

1.9

48.3

803

4822

M01AH05

ATC

etoricoxib; oral

1.8

47.6

2123

16883

M01AE02

ATC

naproxen; oral, rectal

1.7

47.5

2003

15678

NA7BG

NOMESCO Finland

Spine and spinal cord MRI examination with high intensity magnet

8.7

47.4

L04AX07

ATC

dimethyl fumarate; oral

8.5

47.2

N05BA04

ATC

oxazepam; oral

1.8

47.0

914

5756

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.0

46.7

606

3343

N06BA07

ATC

modafinil; oral

10.3

46.7

N02AJ06

ATC

codeine and paracetamol; systemic

1.7

46.6

1479

10698

H47.1

ICD-10 Finland

Papilloedema, unspecified

10.6

46.4

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

3.4

46.4

170

514

M79.1

ICD-10 Finland

Myalgia

2.0

46.3

647

3661

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

6.3

46.3

126

SPAT1301

SPAT

No procedures

1.8

46.2

946

6045

SPAT1263

SPAT

Sampling

1.7

46.2

1394

9939

G81.9

ICD-10 Finland

Hemiplegia, unspecified

7.8

45.9

J01MA02

ATC

ciprofloxacin; systemic

1.7

45.8

1105

7403

C07AA05

ATC

propranolol; systemic

1.8

45.6

808

4939

A06AC01

ATC

ispaghula (psylla seeds); oral

1.9

45.4

791

4809

P01AB01

ATC

metronidazole; oral, rectal

1.7

45.3

1419

10201

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.2

45.3

458

2303

AAF05

NOMESCO Finland

Ventriculoperitoneal shunt

233.2

45.1

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

158.9

44.9

A02BC01

ATC

omeprazole; systemic

1.8

44.3

826

5120

J01FA10

ATC

azithromycin; systemic

1.7

44.3

2110

16910

G44.8

ICD-10 Finland

Other specified headache syndromes

4.3

44.3

116

277

X59

ICD-10 Finland

Exposure to unspecified factor

1.9

43.9

667

3874

R11

ICD-10 Finland

Nausea and vomiting

2.3

43.8

353

1616

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.7

43.7

1102

7452

N05AH04

ATC

quetiapine; oral

1.9

43.5

713

4243

XKD06

NOMESCO Finland

Physiologic investigation of micturition

4.7

43.5

101

219

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.8

42.7

754

4589

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

2.6

42.4

262

1061

R51.81

ICD-10 Finland

Facial pain NOS

3.8

42.2

134

368

TAW99

NOMESCO Finland

Other minor neurosurgical procedure

9.7

42.2

K30

ICD-10 Finland

Functional dyspepsia

2.1

42.0

460

2380

M01AB05

ATC

diclofenac; systemic, rectal

1.7

41.3

2147

17440

SPAT1153

SPAT

Removal of sutures

1.8

41.1

839

5327

M54.2

ICD-10 Finland

Cervicalgia

2.3

40.6

341

1587

J01DB01

ATC

cefalexin; oral

1.9

39.7

2741

23980

A02BA02

ATC

ranitidine; systemic

2.0

39.6

500

2719

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.6

39.5

240

963

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.8

39.2

797

5042

UJF32

NOMESCO Finland

Coloscopy

1.8

39.0

684

4141

N02AA05

ATC

oxycodone; systemic

2.1

38.7

402

2035

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

3.4

38.5

141

426

XKC03

NOMESCO Finland

Water cystometry

4.2

38.4

105

259

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

3.1

38.0

162

537

G50.0

ICD-10 Finland

Trigeminal neuralgia

4.5

37.9

215

R90.8

ICD-10 Finland

Other abnormal findings on diagnostic imaging of central nervous system

5.9

37.9

117

R01AD09

ATC

mometasone; nasal

1.6

37.8

1680

12984

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

2.8

37.8

200

748

G44.1

ICD-10 Finland

Vascular headache, not elsewhere classified

7.6

37.4

Z00.0

ICD-10 Finland

General medical examination

1.8

37.0

627

3751

S06.0

ICD-10 Finland

Concussion

2.1

36.9

386

1957

A01

ICPC

Pain general/multiple sites

2.2

36.9

348

1695

R55

ICD-10 Finland

Syncope and collapse

2.3

36.9

292

1323

C07AB07

ATC

bisoprolol; oral

1.7

36.9

1087

7584

J45.9

ICD-10 Finland

Asthma, unspecified

1.8

36.7

634

3812

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.0

36.7

452

2433

N06AA10

ATC

nortriptyline; systemic

3.9

36.7

111

295

M01AH01

ATC

celecoxib; oral

1.9

36.5

497

2770

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.7

36.4

838

5474

N03AF01

ATC

carbamazepine; oral, rectal

3.0

36.4

165

567

AAF20

NOMESCO Finland

Revision of shunt of ventricle of brain

361.3

36.0

L04AA31

ATC

[U] teriflunomide

9.1

36.0

J02AC01

ATC

fluconazole; systemic

1.6

35.6

1508

11464

G50.1

ICD-10 Finland

Atypical facial pain

4.2

35.5

239

H02AB04

ATC

methylprednisolone; systemic

2.0

35.5

452

2459

G91.2

ICD-10 Finland

Normal-pressure hydrocephalus

+∞

35.5

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.9

35.1

528

3036

H04.10

ICD-10 Finland

Dry eye syndrome

2.0

35.1

434

2337

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

4.0

34.9

101

260

N06AB04

ATC

citalopram; systemic

1.8

34.4

682

4262

M01AC06

ATC

meloxicam; systemic, rectal

1.6

34.4

1045

7319

N04BB01

ATC

amantadine; oral

4.9

34.2

155

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.1

34.1

344

1718

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.9

33.9

487

2757

G54.0

ICD-10 Finland

Brachial plexus disorders

3.0

33.8

150

509

G45.3

ICD-10 Finland

Amaurosis fugax

46.1

33.8

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.0

33.7

396

2092

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.0

33.7

429

2333

J01EA01

ATC

trimethoprim; systemic

1.7

33.6

840

5591

J01FA06

ATC

roxithromycin; oral

1.6

33.4

1242

9117

N06AB10

ATC

escitalopram; oral

1.7

33.3

851

5693

X58

ICD-10 Finland

Exposure to other specified factors

1.8

33.3

554

3285

G44.0

ICD-10 Finland

Cluster headache syndrome

4.7

33.2

167

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.5

33.2

213

877

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.9

33.1

499

2869

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

3.7

32.8

106

295

G04BD12

ATC

mirabegron; oral

2.2

32.7

279

1303

L03AB08

ATC

interferon beta-1b; parenteral

9.4

32.7

H53.9

ICD-10 Finland

Visual disturbance, unspecified

3.0

32.6

150

520

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

2.9

32.4

159

571

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.6

32.3

1639

12875

K07.60

ICD-10 Finland

Snapping jaw

2.3

32.1

271

1260

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.8

32.0

166

614

R13

ICD-10 Finland

Dysphagia

2.5

31.9

218

924

M03BC51

ATC

orphenadrine, combinations; systemic

1.6

31.8

911

6265

SPAT1260

SPAT

Consultation of another employee

1.8

31.5

530

3149

NA2CG

NOMESCO Finland

Thoracal spine extensive MRI examination with high intensity magnet

5.7

31.4

106

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.7

31.4

762

5019

N07XX09

ATC

[U] dimethyl fumarate

9.8

31.2

N05CF01

ATC

zopiclone; oral

1.6

31.2

868

5921

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.6

31.0

2082

17340

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

2.6

30.9

182

718

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.2

30.9

279

1333

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

3.5

30.7

107

313

N29

ICPC

Neurological sympt/complt other

4.2

30.7

199

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.3

30.6

232

1030

N02CC04

ATC

rizatriptan; oral

2.1

30.3

292

1431

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.3

30.3

256

1190

A87.9

ICD-10 Finland

Viral meningitis, unspecified

6.0

30.3

N89

ICPC

Migraine

2.3

30.3

232

1035

CS5Z4

NOMESCO Finland

Specialised imaging for glaucoma

4.1

29.9

207

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

2.0

29.9

379

2054

XCW99

NOMESCO Finland

Other investigative procedure of eye

2.2

29.8

273

1311

R52.1

ICD-10 Finland

Chronic intractable pain

5.7

29.6

SPAT1310

SPAT

Counselling related to known health issue

1.6

29.5

965

6826

R03DC03

ATC

montelukast; oral

1.7

29.4

613

3869

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.1

29.3

299

1497

N02CC03

ATC

zolmitriptan; nasal, oral

2.2

29.3

272

1313

M01AH02

ATC

rofecoxib; oral

2.1

29.3

296

1477

ZYC01

NOMESCO Finland

Remote contact by phone

2.2

29.2

247

1149

M70.6

ICD-10 Finland

Trochanteric bursitis

1.9

29.2

403

2246

R20.0

ICD-10 Finland

Anaesthesia of skin

5.7

29.1

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.8

28.9

484

2865

J05AB01

ATC

aciclovir; systemic

1.7

28.8

737

4906

R07.3

ICD-10 Finland

Other chest pain

2.0

28.7

334

1756

N05BA01

ATC

diazepam; systemic, rectal

1.9

28.6

383

2111

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

2.0

28.5

341

1809

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

2.4

28.4

206

896

R01BA52

ATC

pseudoephedrine, combinations; oral

1.6

28.4

937

6629

G43.8

ICD-10 Finland

Other migraine

3.3

28.4

109

339

R20.1

ICD-10 Finland

Hypoaesthesia of skin

6.3

28.2

D01

ICPC

Abdominal pain/cramps general

1.8

28.2

481

2862

N04BC05

ATC

pramipexole; oral

2.3

28.2

216

963

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.0

28.1

346

1853

R01AD58

ATC

fluticasone, combinations; nasal

1.6

28.1

1035

7508

AA1AA

NOMESCO Finland

Head X-ray examination

8.8

28.1

N02CC07

ATC

frovatriptan; oral

2.2

27.8

236

1099

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

2.0

27.8

326

1718

AA1DM

NOMESCO Finland

Very extensive MRI examination of brain with 3 Tesla magnet

5.5

27.7

N05CF02

ATC

zolpidem; oral

1.7

27.7

577

3635

Z2445

NOMESCO Finland

Psychologist

2.5

27.6

173

704

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.5

27.6

1767

14392

M54.6

ICD-10 Finland

Pain in thoracic spine

2.0

27.4

309

1605

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.4

27.3

187

793

PA7BD

NOMESCO Finland

CT angiography of neck and brain

6.3

27.0

TKC22

NOMESCO Finland

Catheterisation instruction

4.9

26.9

122

TAB20

NOMESCO Finland

Epidural puncture

6.1

26.7

L28

ICPC

Limited function/disability (L)

1.8

26.6

417

2415

R03BA08

ATC

ciclesonide; inhalant

2.0

26.6

312

1643

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.1

26.5

275

1385

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.6

26.3

152

594

M89.0

ICD-10 Finland

Algoneurodystrophy

5.0

26.3

113

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

2.4

26.3

184

788

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.3

26.3

205

921

J01DA01

ATC

[U] cefalexin

1.5

26.2

1930

16092

G91.1

ICD-10 Finland

Obstructive hydrocephalus

+∞

26.1

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.8

26.0

425

2492

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.8

26.0

134

494

M01AX17

ATC

nimesulide; oral

1.7

25.9

553

3501

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.0

25.8

306

1616

N03AG01

ATC

valproic acid; systemic, rectal

2.3

25.7

212

975

N03AF02

ATC

oxcarbazepine; oral

2.9

25.7

123

436

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.9

25.7

326

1764

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.1

25.6

274

1395

AA5BD

NOMESCO Finland

CT of cerebral ischaemia

4.6

25.5

132

NAG40

NOMESCO Finland

Anterior fusion of cervical spine without fixation

3.4

25.4

286

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.5

25.4

1148

8659

J01FF01

ATC

clindamycin; systemic

1.6

25.3

794

5527

Z3231

NOMESCO Finland

Registered nurse

1.6

25.3

750

5152

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.7

25.2

552

3516

A06AD11

ATC

lactulose; oral

2.0

25.2

302

1602

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

2.5

25.1

163

674

R00.2

ICD-10 Finland

Palpitations

1.9

25.1

320

1734

R03BA05

ATC

fluticasone; inhalant

1.7

25.0

608

3977

N06AB06

ATC

sertraline; oral

1.8

25.0

449

2706

SAA01

NOMESCO Finland

Simple examination of mouth

1.6

24.9

2498

22100

F43.1

ICD-10 Finland

Post-traumatic stress disorder

2.5

24.7

163

679

K59.09

ICD-10 Finland

Constipation, unspecified

2.4

24.6

177

768

SPAT1254

SPAT

Administration of medicine

1.8

24.4

383

2217

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

3.6

24.4

230

H57.1

ICD-10 Finland

Ocular pain

2.4

24.3

177

771

SPAT1249

SPAT

Treatment-related counselling outside office

1.5

24.3

1243

9588

J05AB11

ATC

valaciclovir; oral

1.7

24.3

487

3026

O47.0

ICD-10 Finland

False labour before 37 completed weeks of gestation

1.8

24.3

441

2666

J01CA04

ATC

amoxicillin; systemic

1.7

24.2

2736

24789

N99

ICPC

Neurological disease other

5.1

24.2

102

J01FA09

ATC

clarithromycin; systemic

1.5

24.1

1018

7550

R01AD12

ATC

fluticasone furoate; nasal

1.5

24.1

1213

9323

N02CC05

ATC

almotriptan; oral

2.2

24.1

201

929

R33

ICD-10 Finland

Retention of urine

2.6

24.1

143

567

G91.9

ICD-10 Finland

Hydrocephalus, unspecified

+∞

24.0

R06AE07

ATC

cetirizine; oral

1.5

24.0

1512

12141

F51.0

ICD-10 Finland

Nonorganic insomnia

1.6

23.9

713

4897

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.8

23.8

124

460

AEA00

NOMESCO Finland

Replacement of impulse generator of stimulation device in the nervous system

6.8

23.8

L03

ICPC

Low back symptom/complaint

1.5

23.8

997

7381

G04CA02

ATC

tamsulosin; oral

1.9

23.7

298

1605

W19

ICD-10 Finland

Unspecified fall

2.0

23.6

281

1486

C09CA06

ATC

candesartan; oral

1.6

23.5

694

4752

N02BF02

ATC

pregabalin; oral

2.1

23.5

240

1201

SPAT1240

SPAT

Therapeutic discussion

1.7

23.5

445

2721

M01AG02

ATC

tolfenamic acid; oral, rectal

1.7

23.3

555

3605

N02CC06

ATC

eletriptan; oral

2.3

23.3

190

869

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.5

23.3

1843

15412

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.9

23.3

317

1753

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.6

23.3

615

4102

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.0

23.1

246

1250

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.5

23.0

778

5492

AA7AA

NOMESCO Finland

Liquor cerebri shunt X-ray examinatin without contrast

+∞

22.9

XF400

NOMESCO Finland

ECG with 12 standard connections

1.8

22.8

340

1935

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

3.6

22.8

207

G43

ICD-10 Finland

Migraine

1.9

22.7

305

1680

F45.8

ICD-10 Finland

Other somatoform disorders

1.9

22.6

332

1881

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.5

22.6

906

6631

J45

ICD-10 Finland

Asthma

1.8

22.5

370

2169

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.1

22.5

225

1116

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.7

22.5

458

2855

C08DA01

ATC

verapamil; systemic

2.8

22.5

114

417

R02

ICPC

Shortness of breath/dyspnoea

1.8

22.4

374

2203

WX110

NOMESCO Finland

Infiltration anesthesia

1.5

22.4

2393

21135

R03BA01

ATC

beclometasone; inhalant

1.7

22.2

415

2524

N06AX26

ATC

vortioxetine; oral

1.9

22.2

327

1853

C01CA24

ATC

epinephrine; parenteral

2.0

22.2

269

1431

N71.0

ICD-10 Finland

Acute inflammatory disease of uterus

2.3

22.1

169

752

G72.9

ICD-10 Finland

Myopathy, unspecified

6.7

22.1

JN3AD

NOMESCO Finland

Abdominal CT examination

1.8

22.1

353

2053

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.4

22.1

149

628

S18

ICPC

Laceration/cut

1.5

22.0

1257

9854

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.9

21.9

292

1603

B01AB05

ATC

enoxaparin; parenteral

1.5

21.9

783

5586

L08

ICPC

Shoulder symptom/complaint

1.6

21.9

679

4695

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

2.1

21.9

227

1142

G45.0

ICD-10 Finland

Vertebro-basilar artery syndrome

63.0

21.9

C10AC01

ATC

colestyramine; oral

2.9

21.8

104

368

XA402

NOMESCO Finland

ENMG

3.1

21.7

299

N30.0

ICD-10 Finland

Acute cystitis

1.6

21.7

580

3871

SPAT1050

SPAT

Extensive neurological examination

3.6

21.6

200

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.6

21.6

560

3711

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.5

21.6

1042

7902

R06AX27

ATC

desloratadine; oral

1.5

21.5

1103

8459

J01CA08

ATC

pivmecillinam; oral

1.4

21.5

1442

11629

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.0

21.5

262

1396

M54.3

ICD-10 Finland

Sciatica

2.1

21.5

199

959

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

1.9

21.5

269

1447

J01DA09

ATC

[U] cefadroxil

1.5

21.4

834

6053

SPAT1229

SPAT

Assessment of need for aid

2.4

21.4

154

668

N07CA01

ATC

betahistine; oral

2.2

21.4

175

802

SPAT1216

SPAT

Assessment of functional ability

1.9

21.4

304

1704

NGF00

NOMESCO Finland

Excision of plica of synovy of knee

3.1

21.1

304

N06AX03

ATC

mianserin; oral

2.4

21.1

141

591

K08.80

ICD-10 Finland

Toothache NOS

1.8

21.1

371

2217

R01AD08

ATC

fluticasone; nasal

1.5

21.1

977

7341

M54.1

ICD-10 Finland

Radiculopathy

2.4

21.1

143

604

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

2.0

20.9

221

1119

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.6

20.9

569

3812

R21

ICPC

Throat symptom/complaint

1.5

20.9

897

6639

T85.0

ICD-10 Finland

Mechanical complication of ventricular intracranial (communicating) shunt

+∞

20.9

M50.3

ICD-10 Finland

Other cervical disc degeneration

3.2

20.8

260

N31.9

ICD-10 Finland

Neuromuscular dysfunction of bladder, unspecified

6.1

20.8

CS494

NOMESCO Finland

Other visual field testing

3.3

20.6

231

PA2AD

NOMESCO Finland

CT angiography of brain

4.8

20.6

WZC00

NOMESCO Finland

Treatment plan or consultation

1.4

20.5

1149

8941

XF404

NOMESCO Finland

Ambulatory ECG

2.1

20.4

196

958

R96

ICPC

Asthma

1.8

20.4

302

1715

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.1

20.3

194

947

A03FA02

ATC

cisapride; oral, rectal

2.2

20.2

174

814

R39.1

ICD-10 Finland

Other difficulties with micturition

3.2

20.1

260

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.7

20.1

423

2655

N06AX12

ATC

bupropion; oral

1.8

20.1

337

1986

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.3

19.9

154

689

A03

ICPC

Fever

1.5

19.9

674

4739

G62.8

ICD-10 Finland

Other specified polyneuropathies

5.7

19.9

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.4

19.8

1061

8174

L01

ICPC

Neck symptom/complaint

1.6

19.8

584

3981

R4120

NOMESCO Finland

Occupational therapy

2.1

19.8

199

989

R35

ICD-10 Finland

Polyuria

2.2

19.8

165

762

R03AK07

ATC

formoterol and budesonide; inhalant

1.5

19.8

737

5288

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

2.5

19.8

122

493

N31.2

ICD-10 Finland

Flaccid neuropathic bladder, not elsewhere classified

5.8

19.8

A02BC04

ATC

rabeprazole; oral

1.8

19.8

290

1641

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.5

19.7

883

6574

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

2.8

19.6

102

378

ZXE10

NOMESCO Finland

More than one and less than three hours

1.5

19.6

929

6992

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

19.6

1302

10428

R10.2

ICD-10 Finland

Pelvic and perineal pain

2.7

19.6

109

419

NG1BG

NOMESCO Finland

Knee and lower leg MRI examination with high intensity magnet

2.1

19.6

188

919

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.7

19.5

411

2579

A04AA01

ATC

ondansetron; systemic, rectal

2.0

19.5

235

1247

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.3

19.4

153

690

SFA10

NOMESCO Finland

One-surface restoration

1.4

19.4

1858

15835

C07AB02

ATC

metoprolol; systemic

1.7

19.3

368

2247

PA6AD

NOMESCO Finland

CT of neck arteries

2.9

19.3

315

R20.8

ICD-10 Finland

Other and unspecified disturbances of skin sensation

3.8

19.2

159

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.6

19.2

485

3188

7840A

ICD-9 Finland

Symptoms involving head and neck, Headache

4.8

19.2

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

2.1

19.0

180

875

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

3.3

19.0

223

G93.3

ICD-10 Finland

Postviral fatigue syndrome

5.8

18.8

SPAT1028

SPAT

Ultrasound examination of paranasal sinuses

2.0

18.8

221

1162

S83.2

ICD-10 Finland

Tear of meniscus, current

2.0

18.8

221

1163

G04BD08

ATC

solifenacin; oral

2.3

18.8

139

611

H02AB09

ATC

hydrocortisone; systemic

2.9

18.7

309

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.8

18.7

287

1646

A01AB04

ATC

amphotericin B; local oral

2.6

18.7

107

417

7227C

ICD-9 Finland

Intervertebral disk disorders, Intervertebral disk disorder with myelopathy[SYNDROMA ISCHIADICUM]

3.4

18.6

206

M01AC01

ATC

piroxicam; systemic, rectal

1.8

18.6

298

1732

N05BA12

ATC

alprazolam; oral

1.8

18.6

294

1702

A04

ICPC

Weakness/tiredness general

1.6

18.5

506

3385

3007

Kela drug reimbursment

Erenumab and fremanezumab

2.9

18.5

295

ZXA05

NOMESCO Finland

Left side

1.6

18.4

534

3621

R03BA02

ATC

budesonide; inhalant

1.6

18.4

566

3889

M02AA07

ATC

piroxicam; topical

1.5

18.4

849

6345

M22.4

ICD-10 Finland

Chondromalacia patellae

2.3

18.4

137

604

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.6

18.3

484

3212

M01AE01

ATC

ibuprofen; systemic, rectal

1.8

18.3

2985

28090

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.9

18.1

238

1300

DFF00

NOMESCO Finland

Pure tone audiometry

1.9

18.1

240

1315

ZXA10

NOMESCO Finland

Bilateral

1.6

18.1

433

2806

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.7

18.1

323

1937

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.7

18.0

330

1992

R03AC03

ATC

terbutaline; inhalant

1.6

18.0

440

2864

Z71.8

ICD-10 Finland

Other specified counselling

1.4

18.0

1147

9079

S83.6

ICD-10 Finland

Sprain and strain of other and unspecified parts of knee

1.9

18.0

220

1173

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.9

18.0

220

1173

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

2.6

18.0

102

396

ZXA00

NOMESCO Finland

Right side

1.5

17.9

572

3963

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.5

17.8

689

4967

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.6

17.8

475

3158

K07.63

ICD-10 Finland

Pain in the jaw joint UNS

2.7

17.7

358

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.8

17.7

268

1529

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

2.1

17.7

163

783

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.6

17.7

477

3178

C08CA05

ATC

nifedipine; systemic

2.3

17.7

137

614

XKD03

NOMESCO Finland

Urethral pressure profilometry

3.4

17.5

184

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.4

17.4

122

523

Z3226

NOMESCO Finland

Physiotherapist

1.6

17.4

469

3125

R12

ICD-10 Finland

Heartburn

1.8

17.4

283

1652

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.8

17.3

276

1600

R05

ICPC

Cough

1.5

17.3

791

5888

R09

ICPC

Sinus symptom/complaint

1.7

17.3

342

2109

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

2.0

17.2

195

1013

G47.3

ICD-10 Finland

Sleep apnoea

1.5

17.1

606

4286

G51.0

ICD-10 Finland

Bell palsy

2.8

17.1

319

WZA90

NOMESCO Finland

Other medical or dental certificate

1.5

17.0

726

5330

I49.3

ICD-10 Finland

Ventricular premature depolarization

1.9

17.0

205

1087

M47.9

ICD-10 Finland

Spondylosis, unspecified

2.9

17.0

276

J46

ICD-10 Finland

Status asthmaticus

2.6

17.0

372

R25.2

ICD-10 Finland

Cramp and spasm

2.8

17.0

304

T78.4

ICD-10 Finland

Allergy, unspecified

2.0

16.9

190

983

J45.1

ICD-10 Finland

Nonallergic asthma

2.0

16.9

202

1068

H92.0

ICD-10 Finland

Otalgia

1.8

16.9

252

1432

A06AC51

ATC

ispaghula, combinations; oral

2.2

16.8

139

640

J31.0

ICD-10 Finland

Chronic rhinitis

1.7

16.8

300

1797

SPAT1097

SPAT

Recording of ECG

1.7

16.8

299

1790

EB1VA, ,

NOMESCO Finland

1.5

16.8

598

4235

P01

ICPC

Feeling anxious/nervous/tense

1.5

16.7

591

4179

G96.0

ICD-10 Finland

Cerebrospinal fluid leak

+∞

16.7

ABD32

NOMESCO Finland

Implantation of temporary spinal stimulation device

5.8

16.6

SPAT1053

SPAT

Memory test

2.1

16.6

157

763

G93.0

ICD-10 Finland

Cerebral cysts

90.5

16.6

U01

ICPC

Dysuria/painful urination

1.8

16.5

271

1584

AAF99

NOMESCO Finland

Other shunt operation on ventricle of brain or intracerebral cyst

170.9

16.5

G95.8

ICD-10 Finland

Other specified diseases of spinal cord

170.9

16.5

XQ800

NOMESCO Finland

Prick test

1.7

16.4

288

1717

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.4

16.4

1237

10031

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.7

16.3

343

2147

D02

ICPC

Abdominal pain epigastric

1.9

16.3

218

1197

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

2.5

16.3

106

440

J01FA15

ATC

telithromycin; oral

1.7

16.3

305

1852

G04CA01

ATC

alfuzosin; oral

2.1

16.2

164

817

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.7

16.2

345

2166

H81.3

ICD-10 Finland

Other peripheral vertigo

2.8

16.2

300

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.6

16.2

368

2349

N06AX22

ATC

agomelatine; oral

2.4

16.2

108

453

WX725

NOMESCO Finland

Noninvasive ventilation

2.0

16.2

168

845

A06AX04

ATC

linaclotide; oral

6.5

16.2

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.3

16.2

125

560

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

2.1

16.1

148

711

WX408

NOMESCO Finland

General anesthesy, balanced

1.5

16.1

681

4985

R06.4

ICD-10 Finland

Hyperventilation

3.1

16.1

215

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

2.7

16.1

313

A03CA02

ATC

clidinium and psycholeptics; oral

2.3

16.0

122

543

ZX120

NOMESCO Finland

Intravenous

1.8

16.0

237

1345

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.5

15.9

101

414

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.7

15.9

311

1909

N02CC02

ATC

naratriptan; oral

2.7

15.9

309

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.6

15.9

351

2225

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.7

15.9

308

1888

L12

ICPC

Hand/finger symptom/complaint

1.5

15.8

547

3845

K80

ICPC

Cardiac arrhythmia NOS

1.8

15.8

230

1297

D06

ICPC

Abdominal pain localized other

1.7

15.8

313

1929

G47.9

ICD-10 Finland

Sleep disorder, unspecified

2.3

15.8

117

515

PA2BD

NOMESCO Finland

Extensive CT angiography of brain

3.4

15.8

162

A05

ICPC

Feeling ill

1.8

15.7

236

1343

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

3.0

15.7

234

G91.0

ICD-10 Finland

Communicating hydrocephalus

+∞

15.6

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.4

15.6

782

5908

SPAT1312

SPAT

General health counselling

1.4

15.5

950

7426

M01AH03

ATC

valdecoxib; oral

2.1

15.5

148

722

M01AB55

ATC

diclofenac, combinations; oral

2.1

15.5

139

662

H93.1

ICD-10 Finland

Tinnitus

1.9

15.5

202

1101

D11

ICPC

Diarrhoea

1.6

15.4

446

3014

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.0

15.4

169

867

F06.7

ICD-10 Finland

Mild cognitive disorder

3.7

15.4

131

D86.8

ICD-10 Finland

Sarcoidosis of other and combined sites

4.7

15.4

WYA10

NOMESCO Finland

Emergency care or similar visit

1.8

15.4

257

1510

JAH01

NOMESCO Finland

Laparoscopy

2.0

15.4

172

889

R05

ICD-10 Finland

Cough

1.5

15.3

644

4703

M35.7

ICD-10 Finland

Hypermobility syndrome

2.7

15.3

304

CS434

NOMESCO Finland

Visual field testing with Humphrey automated perimetry

3.0

15.3

227

N18

ICPC

Paralysis/weakness

4.0

15.2

105

R74

ICPC

Upper respiratory infection acute

1.4

15.1

1315

10863

SPAT1255

SPAT

Intravenous administration of medicine

2.0

15.1

162

825

H03AA01

ATC

levothyroxine sodium; systemic

1.4

15.0

672

4964

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.4

15.0

1113

8968

M23.8

ICD-10 Finland

Other internal derangements of knee

2.1

15.0

141

684

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.2

15.0

133

631

OAB93, ,

SPAT

1.6

14.9

328

2076

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

1.9

14.9

199

1092

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.4

14.9

945

7421

A01AB09

ATC

miconazole; local oral

1.8

14.9

212

1187

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

1.9

14.9

179

949

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

2.3

14.9

107

465

B02AA02

ATC

tranexamic acid; systemic

1.5

14.9

532

3763

J01MA14

ATC

moxifloxacin; systemic

1.8

14.8

232

1337

M75.8

ICD-10 Finland

Other shoulder lesions

2.1

14.8

145

714

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.5

14.8

435

2949

H49.2

ICD-10 Finland

Sixth [abducent] nerve palsy

5.5

14.8

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

2.0

14.8

164

846

ZXE00

NOMESCO Finland

One hour or less

1.4

14.7

1125

9104

N07AA02

ATC

pyridostigmine; systemic

6.1

14.7

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.9

14.7

185

997

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

14.6

1301

10771

J35.0

ICD-10 Finland

Chronic tonsillitis

1.7

14.6

249

1472

M51.8

ICD-10 Finland

Other specified intervertebral disc disorders

3.5

14.5

146

-1, ,

NOMESCO Finland

1.4

14.5

1111

8983

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.6

14.5

420

2839

D07AC01

ATC

betamethasone; topical

1.4

14.5

1018

8122

F45.9

ICD-10 Finland

Somatoform disorder, unspecified

5.8

14.5

R25.1

ICD-10 Finland

Tremor, unspecified

2.6

14.4

319

N03AX14

ATC

levetiracetam; systemic

2.7

14.4

302

J20

ICD-10 Finland

Acute bronchitis

1.6

14.4

334

2142

WX704

NOMESCO Finland

Intubation

1.8

14.4

237

1387

N02AC04

ATC

dextropropoxyphene; oral

2.9

14.4

235

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.0

14.4

163

847

AA1BM

NOMESCO Finland

MRI examination of brain with 3 Tesla magnet

3.6

14.4

128

WX290

NOMESCO Finland

Other blockage of nerve

1.3

14.4

1717

14833

H53.4

ICD-10 Finland

Visual field defects

3.3

14.4

157

K59.1

ICD-10 Finland

Functional diarrhoea

1.9

14.4

172

911

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.6

14.3

338

2178

UJD02

NOMESCO Finland

Gastroscopy

2.2

14.2

118

545

R4110, ,

SPAT

1.6

14.2

342

2214

WX002

NOMESCO Finland

Sedation and analgesia

1.5

14.1

433

2961

P06

ICPC

Sleep disturbance

1.5

14.1

448

3087

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.6

14.1

305

1922

NGF35

NOMESCO Finland

Plastic operation of joint cartilage of knee

2.4

14.1

389

SHA04

NOMESCO Finland

Stomatognathic treatment, very demanding

3.0

14.1

200

N76.0

ICD-10 Finland

Acute vaginitis

1.6

14.0

326

2091

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

2.6

14.0

312

J01CE02

ATC

phenoxymethylpenicillin; oral

1.4

14.0

2217

19931

R00.0

ICD-10 Finland

Tachycardia, unspecified

2.0

14.0

148

751

UDC00

NOMESCO Finland

Ear microscopy

1.8

13.9

202

1138

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

3.2

13.8

176

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

1.8

13.8

192

1068

N32.82

ICD-10 Finland

Instability of the detrusor vesicae muscle

3.9

13.8

104

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.6

13.7

300

1897

I49.4

ICD-10 Finland

Other and unspecified premature depolarization

2.2

13.6

113

522

SPAT1231

SPAT

Assessment of adjustments needed in living environment

4.3

13.6

R01AD01

ATC

beclometasone; nasal

1.5

13.5

468

3282

L13

ICPC

Hip symptom/complaint

1.5

13.5

464

3249

S43.4

ICD-10 Finland

Sprain and strain of shoulder joint

2.0

13.5

142

719

K59.0

ICD-10 Finland

Constipation

2.0

13.5

144

733

A11

ICPC

Chest pain NOS

1.8

13.5

204

1165

Z3229

NOMESCO Finland

Other healthcare associate professional

1.9

13.4

183

1011

AEA20

NOMESCO Finland

Removal of impulse generator of stimulation device in the nervous system

16.3

13.4

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

1.9

13.4

159

839

G56.4

ICD-10 Finland

Causalgia

5.2

13.4

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.7

13.4

245

1476

SAA02

NOMESCO Finland

Basic examination of mouth

1.4

13.4

2307

20922

A02BA04

ATC

nizatidine; systemic

2.0

13.4

146

749

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.4

13.4

877

6904

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

1.9

13.3

167

898

L17

ICPC

Foot/toe symptom/complaint

1.4

13.3

852

6679

UJF92

NOMESCO Finland

Capsular endoscopy

2.6

13.3

291

B34.9

ICD-10 Finland

Viral infection, unspecified

2.2

13.3

116

547

N02CD01

ATC

erenumab; parenteral

3.2

13.3

170

R03AK08

ATC

formoterol and beclometasone; inhalant

2.0

13.3

142

723

I83.9

ICD-10 Finland

Varicose veins of lower extremities without ulcer or inflammation

1.7

13.3

254

1550

SPAT1210

SPAT

Application of cast or individual aid

2.1

13.3

120

574

R03BB04

ATC

tiotropium bromide; inhalant

1.8

13.2

183

1017

WZC30, ,

SPAT

1.7

13.2

225

1331

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.6

13.1

318

2060

KCV04

NOMESCO Finland

Distension of bladder with fluid

4.3

13.1

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.3

13.1

440

S80.0

ICD-10 Finland

Contusion of knee

1.7

13.1

264

1634

EMB10

NOMESCO Finland

Tonsillectomy

1.7

13.1

252

1541

WZC30

NOMESCO Finland

Teaching

1.5

13.1

410

2817

RF420, ,

NOMESCO Finland

3.4

13.0

132

M48.0

ICD-10 Finland

Spinal stenosis

1.8

13.0

198

1132

WX400

NOMESCO Finland

Inhalation anesthesy

2.0

13.0

144

743

XPX04

NOMESCO Finland

Angioscopy

5.2

13.0

R41.0

ICD-10 Finland

Disorientation, unspecified

3.1

12.9

168

N02CD06

ATC

rimegepant; oral

3.5

12.9

128

H01

ICPC

Ear pain/earache

1.5

12.9

417

2884

SFA20

NOMESCO Finland

Two-surface restoration

1.3

12.8

1941

17209

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.1

12.8

120

582

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.7

12.8

263

1635

X50

ICD-10 Finland

Overexertion and strenuous or repetitive movements

2.6

12.8

268

S01GX01

ATC

cromoglicic acid; ophthalmic

1.4

12.8

688

5238

R41.3

ICD-10 Finland

Other amnesia

2.9

12.7

212

F05

ICPC

Visual disturbance other

2.3

12.7

420

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.8

12.7

181

1014

UJF30

NOMESCO Finland

Ileoscopy through colon

1.6

12.7

280

1773

M25.2

ICD-10 Finland

Flail joint

3.1

12.7

175

M24.2

ICD-10 Finland

Disorder of ligament

2.9

12.6

208

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.7

12.6

250

1541

SPAT1307

SPAT

Psychosocial counselling and guidance

1.7

12.6

255

1580

CS444

NOMESCO Finland

Visual field testing with Octopus automated perimetry

2.4

12.5

348

G40.9

ICD-10 Finland

Epilepsy, unspecified

2.4

12.5

379

N05AB04

ATC

prochlorperazine; systemic, rectal

3.1

12.5

171

N07BC02

ATC

methadone; systemic

6.2

12.5

B01AC04

ATC

clopidogrel; oral

1.8

12.4

181

1021

AAF25

NOMESCO Finland

Removal of shunt of ventricle of brain

130.5

12.4

D07AB02

ATC

hydrocortisone butyrate; topical

1.4

12.4

863

6841

SPAT1104

SPAT

Monitoring of emergency patient

1.9

12.4

153

819

B03BA03

ATC

hydroxocobalamin; parenteral

2.2

12.4

101

464

U02

ICPC

Urinary frequency/urgency

1.5

12.4

424

2966

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.8

12.3

227

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.6

12.3

297

1922

N92.0

ICD-10 Finland

Excessive and frequent menstruation with regular cycle

1.5

12.3

424

2969

H81.4

ICD-10 Finland

Vertigo of central origin

5.4

12.3

N17

ICPC

Vertigo/dizziness

1.6

12.3

315

2068

N06AX05

ATC

trazodone; oral

2.3

12.3

389

G04BD11

ATC

fesoterodine; oral

2.9

12.2

195

2AB04, ,

NOMESCO Finland

9.0

12.2

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

1.9

12.2

142

745

N02CX04, ,

ATC

2.8

12.2

206

N20.1

ICD-10 Finland

Calculus of ureter

2.4

12.2

371

P76

ICPC

Depressive disorder

1.6

12.1

272

1729

R06AE09

ATC

levocetirizine; oral

1.5

12.1

488

3522

G03DC03

ATC

lynestrenol; oral

2.2

12.1

436

M01AX01

ATC

nabumetone; oral

2.3

12.0

405

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.6

12.0

276

1765

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

2.8

12.0

208

M77.4

ICD-10 Finland

Metatarsalgia

1.7

12.0

209

1243

M05BA07

ATC

risedronic acid; oral

3.1

12.0

165

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

3.0

12.0

181

PA2BG

NOMESCO Finland

MRI examination of vessels in the head with high intensity magnet

4.2

12.0

GD1AA, ,

SPAT

1.4

12.0

595

4462

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.3

12.0

381

J03.9

ICD-10 Finland

Acute tonsillitis, unspecified

1.7

11.9

223

1352

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

1.6

11.9

261

1649

WZC00, ,

SPAT

1.5

11.9

434

3072

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

1.9

11.9

145

773

N02AJ13

ATC

tramadol and paracetamol; systemic

2.6

11.9

272

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.5

11.9

362

2470

Z35.8

ICD-10 Finland

Supervision of other high-risk pregnancies

1.5

11.8

389

2696

AA1BG, ,

SPAT

2.4

11.8

327

K02.1

ICD-10 Finland

Caries of dentine

1.3

11.8

1978

17680

R06AX22

ATC

ebastine; oral

1.4

11.8

567

4225

G83.4

ICD-10 Finland

Cauda equina syndrome

5.9

11.8

NXL00

NOMESCO Finland

Biopsy of muscle

5.9

11.8

N05CD07

ATC

temazepam; oral

1.8

11.8

191

1113

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.8

11.8

170

957

M54

ICD-10 Finland

Dorsalgia

1.5

11.8

434

3079

F48.0

ICD-10 Finland

Neurasthenia

10.5

11.7

6421

FHL

Appendicectomy

1.9

11.7

152

827

XF405

NOMESCO Finland

Symptom ECG

5.1

11.7

RD211, ,

NOMESCO Finland

2.1

11.7

111

541

H02AB07

ATC

prednisone; oral

1.6

11.7

321

2139

J37.0

ICD-10 Finland

Chronic laryngitis

2.2

11.7

442

AA1BD

NOMESCO Finland

Extensive CT of head and brain

2.8

11.7

200

SFA00

NOMESCO Finland

Small restoration

1.5

11.7

424

2998

E0000UV, ,

ATC

1.3

11.7

1250

10524

N06AB03

ATC

fluoxetine; oral

1.5

11.6

361

2472

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

3.4

11.6

122

W22

ICD-10 Finland

Striking against or struck by other object(s)

1.7

11.6

201

1193

L04

ICPC

Chest symptom/complaint

1.8

11.6

189

1103

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

2.4

11.6

336

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.3

11.6

1236

10397

J01MA12

ATC

levofloxacin; systemic

1.5

11.6

397

2776

RF120, ,

NOMESCO Finland

3.5

11.6

108

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

2.6

11.5

241

N06AB05

ATC

paroxetine; oral

1.8

11.5

187

1090

J01DA06

ATC

[U] cefuroxime

1.5

11.5

396

2770

K07.61

ICD-10 Finland

Cracking jaw joint

2.2

11.5

439

K10.3

ICD-10 Finland

Alveolitis of jaws

1.8

11.5

187

1091

SFA30

NOMESCO Finland

Three-surface restoration

1.3

11.5

1235

10396

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

1.5

11.5

366

2520

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.7

11.5

236

M09AX01

ATC

hyaluronic acid; parenteral

2.5

11.5

283

KMAK, ,

NOMESCO Finland

1.3

11.5

1705

14975

AB5CT

NOMESCO Finland

Blockage of nerv root with CT guidance

4.0

11.5

G95.9

ICD-10 Finland

Disease of spinal cord, unspecified

120.4

11.4

KCV12

NOMESCO Finland

Urinary bladder endoscopic botulin therapy

4.5

11.4

SPAT1283

SPAT

Restricted health certificate

1.4

11.4

734

5738

I73.0

ICD-10 Finland

Raynaud syndrome

2.5

11.4

278

M17.3

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

309

250

13.56

318.77

1.1

1.0

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

601

578

12.55

307.65

1.4

1.2

1884.49

8320.08

e6/l

0.47

495

446

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

678

656

12.82

307.65

1.3

1.2

381.82

495.69

mg/l

5.67

648

628

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

597

566

12.71

307.65

1.3

1.2

16.99

34.75

e6/l

0.73

469

412

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

600

587

12.33

307.65

1.3

1.1

3.50

3.68

mmol/l

3.25

565

558

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

329

261

13.92

307.65

1.1

1.0

210.20

222.17

mg/l

0.35

289

226

(3044290) Cell count panel - Cerebral spinal fluid

526

547

11.29

307.65

1.3

1.2

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

334

266

13.89

307.65

1.2

1.1

32.68

36.30

mg/l

0.53

279

220

(4027681) Cerebrospinal fluid IgG ratio and IgG index

279

204

14.88

305.17

1.2

0.61

0.63

ratio

0.19

188

120

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

308

291

11.60

287.35

1.1

1.0

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

231

185

13.37

238.89

1.1

1.0

1.10

1.06

u/l

0.20

101

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

175

126

14.63

192.16

1.3

1.1

66.63

70.63

—

(3016018) Differential panel - Cerebral spinal fluid

240

307

8.37

177.25

1.3

1.2

—

(3023410) Appearance of Cerebral spinal fluid

222

277

8.53

167.23

1.4

1.3

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

189

198

10.08

162.89

1.3

1.2

1.70

2.01

mmol/l

2.16

176

186

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

650

2177

3.49

157.10

2.8

2.4

24.50

19.75

au/ml

0.69

311

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

618

2034

3.52

153.23

1.5

1.3

40.03

48.37

au/ml

0.36

128

(3005719) IgG [Mass/volume] in Serum or Plasma

653

2231

3.42

152.59

2.8

2.7

10.15

10.67

g/l

3.10

596

2082

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1310

6802

2.56

138.88

2.5

2.0

118.38

206.33

u/l

3.59

1265

6488

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

165

197

8.77

128.46

1.4

1.3

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1406

8428

2.18

98.10

3.7

2.8

23.55

49.29

ng/l

1.35

702

4297

(3024561) Albumin [Mass/volume] in Serum or Plasma

1668

10710

2.15

97.23

4.7

37.44

36.96

g/l

3.57

1586

10120

(3013826) Glucose [Moles/volume] in Serum or Plasma

2105

14858

2.20

95.23

5.1

4.5

6.08

6.40

mmol/l

15.17

2015

13722

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

11.96

90.48

1.2

1.1

16.67

18.90

—

(3006315) Basophils [#/volume] in Blood

2054

14578

2.12

88.54

7.9

6.4

0.04

e9/l

0.04

1903

12796

(3001604) Monocytes [#/volume] in Blood

2052

14568

2.12

88.25

7.8

6.4

0.53

0.54

e9/l

3.28

1901

12798

(3032080) INR in Blood by Coagulation assay

1517

9657

2.08

87.41

10.2

9.0

1.10

1.12

inr

1.44

1309

7940

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1350

8261

2.09

86.24

2.9

2.5

53.51

58.11

u/l

3.56

1263

7717

(3019198) Lymphocytes [#/volume] in Blood

2082

14956

2.10

85.49

7.9

6.4

1.89

1.98

e9/l

3.80

1955

13479

(3013115) Eosinophils [#/volume] in Blood

2087

15072

2.09

83.56

8.0

6.7

0.18

0.19

e9/l

0.37

1945

13466

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1737

11746

2.04

83.35

6.6

6.4

1.21

mmol/l

0.00

1521

10229

(3018677) aPTT in Platelet poor plasma by Coagulation assay

674

3163

2.43

82.32

2.0

2.2

29.00

29.23

0.37

650

3069

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

2599

20638

2.33

78.67

5.5

4.1

8.62

9.71

mm/h

6.54

2509

19569

(3036481) Cortisol [Moles/volume] in Serum or Plasma

611

2856

2.41

74.61

2.4

2.1

360.30

375.59

nmol/l

1.33

577

2667

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1877

13366

1.97

74.11

5.7

6.0

9.35

10.39

umol/l

7.67

1798

12722

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2545

20230

2.22

73.66

8.4

7.6

71.38

74.95

u/l

6.44

2456

19322

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

10.77

72.65

1.1

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1541

10343

1.94

71.71

5.9

1.21

mmol/l

0.38

1463

9672

(3013650) Neutrophils [#/volume] in Blood by Automated count

2151

16163

1.99

71.22

9.7

9.4

3.87

3.99

e9/l

1.95

1986

14189

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1061

6317

2.01

69.64

1.5

1.3

21.80

24.55

iu/ml

0.37

312

1859

(3037522) Nuclear Ab [Titer] in Serum

855

4729

2.10

68.52

1.6

1.4

486.59

543.01

titre

0.39

176

970

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

1340

8702

1.92

67.73

4.3

3.1

—

2.46

—

(3009261) Glucose [Presence] in Urine by Test strip

2045

15345

1.91

64.97

5.0

3.4

0.01

0.11

estimate

0.52

475

3030

(3021601) Nitrite [Presence] in Urine by Test strip

2019

15103

1.90

64.58

4.9

3.4

0.00

estimate

1.34

485

3117

(3035350) Ketones [Presence] in Urine by Test strip

2033

15242

1.90

64.57

5.0

3.4

0.00

5.01

estimate

2.77

483

3146

(3015736) pH of Urine

1704

12168

1.85

62.16

4.2

3.1

6.26

6.20

1.68

1018

7100

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

121

7.54

61.96

1.1

—

(3031040) Bacteria [#/volume] in Urine by Automated count

2308

18184

1.94

61.25

6.2

4.0

317.97

1716.14

e6/l

1.92

197

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1063

6579

1.92

60.58

2.1

1.8

0.80

0.91

mg/l

0.84

788

4964

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

9.53

59.91

1.3

1.1

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

100

8.18

59.80

1.1

20.88

245.62

ng/l

0.82

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

318

1210

2.81

58.62

2.3

2.1

39.25

40.37

u/l

0.47

300

1125

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

956

5766

1.93

58.50

1.5

1.3

5.26

9.49

u/ml

2.50

444

2414

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

8.13

58.05

1.0

818.35

788.50

ng/l

0.15

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

8.05

57.57

1.0

337.31

295.22

ng/l

0.51

(3019069) Monocytes/Leukocytes in Blood

1812

13374

1.81

57.45

8.0

6.5

8.42

8.38

0.30

1753

12660

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

100

7.97

57.08

1.0

50.63

36.94

ng/l

1.18

(3006504) Eosinophils/Leukocytes in Blood

1807

13345

1.80

56.99

7.9

6.4

2.84

2.79

0.39

1743

12613

(3015171) Extractable nuclear Ab [Units/volume] in Serum

335

1330

2.69

56.83

1.4

1.3

1.53

0.99

u/ml

0.25

(3022096) Basophils/Leukocytes in Blood

1801

13338

1.79

55.75

8.0

6.5

0.70

0.69

0.31

1733

12576

(40760892) CBC W Ordered Manual Differential panel - Blood

1140

7391

1.84

55.00

5.0

4.4

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

8.68

54.24

2.8

2.3

—

(3020630) Protein [Mass/volume] in Serum or Plasma

359

1512

2.55

53.92

2.0

2.5

67.50

67.72

g/l

0.24

338

1417

(3002030) Lymphocytes/Leukocytes in Blood

1847

13871

1.77

53.59

7.9

6.4

29.55

29.40

0.27

1797

13259

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1620

11721

1.77

53.47

4.8

3.2

0.03

0.07

estimate

0.39

422

2609

(3018010) Neutrophils/Leukocytes in Blood

1823

13647

1.77

53.41

7.7

6.3

56.26

56.41

0.25

1784

13126

(3029937) Albumin [Presence] in Urine by Test strip

1202

8000

1.80

52.62

5.2

3.5

0.01

0.00

estimate

0.44

467

2981

(3015377) Calcium [Moles/volume] in Serum or Plasma

1265

8548

1.79

52.60

2.7

3.3

2.34

2.35

mmol/l

2.96

1172

7955

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1741

13005

1.74

50.02

2.8

2.4

77.62

74.28

nmol/l

5.61

1649

12213

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

822

4945

1.89

49.33

1.7

1.6

28336053.33

35023676.43

pmol/l

0.14

727

4300

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

134

6.33

49.28

1.1

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

173

5.57

48.79

1.1

0.13

5.56

nmol/l

0.95

(3018418) pH of Serum or Plasma

1065

7000

1.78

47.54

3.7

3.8

7.39

7.40

0.67

782

4877

(3019550) Sodium [Moles/volume] in Serum or Plasma

3044

27492

2.88

45.22

17.8

12.5

139.80

139.64

mmol/l

4.35

3019

26956

(3000850) Epithelial cells [#/volume] in Urine

858

5367

1.82

44.77

3.4

2.5

6.03

7.45

e6/l

2.36

800

4858

(3002582) Erythrocytes [#/volume] in Urine

1163

7945

1.73

44.66

4.1

3.0

15.81

86.56

e6/l

3.09

947

5888

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2723

23527

2.01

44.63

5.8

4.6

14.53

14.39

pmol/l

2.78

2615

22212

(3023103) Potassium [Moles/volume] in Serum or Plasma

3046

27570

2.86

44.08

17.9

12.6

3.91

3.92

mmol/l

3.19

3015

26968

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

7.15

44.08

1.1

1.0

—

(3019150) Specific gravity of Urine by Refractometry

1006

6629

1.75

43.76

4.8

3.4

1.02

1.48

kg/l

0.80

667

4336

(3021960) Folate [Moles/volume] in Serum or Plasma

972

6404

1.74

41.96

1.7

1.6

19.71

20.32

nmol/l

0.71

866

5658

(3023368) Bacteria identified in Blood by Culture

890

5739

1.76

41.34

4.1

4.0

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

103

6.52

40.50

1.2

1.4

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1433

10571

1.64

39.73

2.2

1.9

99.94

98.31

pmol/l

0.68

845

5771

(3048689) Calprotectin [Mass/mass] in Stool

752

4676

1.79

39.27

2.5

2.6

106.36

103.19

ug/g

0.10

590

3749

(3011412) CD3 cells [#/volume] in Blood

110

278

4.06

38.94

2.5

1244.77

1359.05

e6/l

0.71

239

(3026008) Bacteria identified in Urine by Culture

1076

7413

1.68

38.75

3.6

2.5

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

3073

28211

2.86

38.08

18.6

12.2

16.98

20.35

mg/l

9.44

2629

22715

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1164

8259

1.64

36.95

1.5

1.4

1.36

1.49

u/ml

0.16

363

2403

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

586

3452

1.85

36.23

2.0

1.8

—

(3030467) Casts [#/volume] in Urine by Automated count

1001

6864

1.66

36.18

3.8

2.9

0.15

0.30

e6/l

5.16

789

4864

(3028026) IgM [Mass/volume] in Serum or Plasma

356

1768

2.14

35.91

2.3

1.8

1.18

1.37

g/l

1.92

340

1655

(3041096) Erythrocytes [Presence] in Urine by Automated

1225

8902

1.61

34.71

3.9

2.8

0.01

0.17

estimate

0.92

430

2547

(3044889) 12 lead EKG panel

2167

18030

1.61

34.13

3.9

3.2

0.17

15847.69

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

251

1103

2.38

33.94

5.9

7.1

24.31

24.30

mmol/l

0.02

240

1054

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

7.89

33.63

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

7.48

33.51

1.1

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1682

13245

1.56

33.16

2.9

2.6

—

estimate

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

440

2427

1.94

33.08

6.3

5.1

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2942

26769

2.12

32.51

7.0

5.4

1.66

1.76

mu/l

6.70

2847

25527

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

443

2464

1.92

32.45

1.9

1.7

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

993

6946

1.62

32.43

2.4

2.2

2.61

mg/l

0.00

900

6071

(3018095) Leukocytes [#/volume] in Urine

1309

9779

1.57

32.29

5.0

3.5

33.97

75.55

e6/l

3.44

1004

6479

(3012095) Magnesium [Moles/volume] in Serum or Plasma

615

3797

1.77

32.15

3.0

3.4

0.84

0.82

mmol/l

2.18

581

3613

(3020891) Body temperature

203

830

2.54

32.07

4.7

4.2

36.95

36.93

°c

0.35

203

824

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

7.81

31.90

1.1

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

659

4187

1.72

31.00

3.7

3.1

99.85

507.93

ng/l

5.25

339

2515

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1983

16359

1.55

30.58

3.8

3.2

78.58

84.80

ug/l

1.33

1912

15621

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

759

5043

1.66

30.06

2.6

2.8

374.62

750.26

ng/l

8.40

627

4109

(3021589) Normoblasts [#/volume] in Blood

1610

12730

1.53

29.92

13.0

9.8

0.00

e9/l

1.40

1398

10395

(3014148) Varicella zoster virus Ab [Titer] in Serum

162

613

2.73

29.89

1.3

1.2

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

7.01

29.68

1.1

—

(3019309) Folate [Moles/volume] in Red Blood Cells

539

3273

1.78

29.61

1.8

1.7

1202.44

1161.42

nmol/l

0.54

435

2558

(3026782) Osmolality of Urine

702

4589

1.68

29.53

3.4

2.6

536.74

528.90

mosm/kgh2o

0.40

641

4010

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

420

2372

1.89

29.19

1.9

1.8

—

(36304419) Bacteria [Presence] in Urine

949

6701

1.59

29.19

3.7

2.8

0.72

0.39

estimate

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

227

1024

2.31

28.84

2.2

2.1

1.16

1.19

g/l

0.58

217

973

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

6.85

28.43

1.1

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

453

2656

1.82

27.87

2.8

2.3

7123.83

5992.15

u/l

0.30

161

1073

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

219

991

2.30

27.61

2.2

2.1

0.23

g/l

0.01

209

942

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

203

3.96

27.39

2.6

2.5

490.34

582.42

e6/l

0.77

158

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

10.09

27.39

1.1

1.0

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

10.09

27.39

1.1

1.0

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

210

3.88

26.93

3.0

2.6

223.77

220.87

e6/l

0.05

173

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

670

4427

1.65

26.71

2.4

2.6

2.41

2.42

mmol/l

2.63

601

3970

(3007164) IgA [Mass/volume] in Serum or Plasma

975

7052

1.55

26.48

1.7

1.5

2.06

2.20

g/l

2.27

705

4662

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

213

3.83

26.40

2.3

2.1

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

185

797

2.40

26.09

3.5

3.2

24.91

25.21

mmol/l

0.57

180

763

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

8.97

25.95

1.1

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

358

1998

1.89

25.66

5.2

3.7

5.78

5.81

kpa

0.31

351

1943

(40768797) Stomach Pathology biopsy report

581

3748

1.67

25.28

1.3

1.2

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1116

8386

1.51

25.04

1.9

1.7

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

3136

29710

2.95

24.97

20.4

14.2

69.13

70.05

umol/l

2.29

3126

29413

(3027801) Oxygen [Partial pressure] in Arterial blood

380

2190

1.83

24.57

6.0

8.8

13.01

13.21

kpa

0.29

367

2114

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

380

2190

1.83

24.57

6.0

8.8

4.98

5.10

kpa

1.96

365

2110

(3016502) Oxygen saturation in Arterial blood

344

1923

1.88

24.49

6.0

9.4

96.71

95.96

1.97

330

1868

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1282

9954

1.48

24.25

3.7

3.2

27.07

30.56

u/l

3.26

1220

9501

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

185

824

2.32

24.18

4.9

5.5

1.61

1.63

0.08

174

779

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

225

1088

2.15

24.08

1.7

1.6

0.04

0.47

iu/ml

1.43

175

(3023420) DNA double strand Ab [Units/volume] in Serum

269

1400

2.01

23.64

2.3

2.1

6.99

7.48

iu/ml

0.12

332

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

230

3.54

23.63

1.2

1.1

1962.80

1460.61

miu/ml

2.72

230

(3024354) Oxygen [Partial pressure] in Venous blood

306

1668

1.92

23.50

5.3

3.1

4.43

4.70

kpa

1.82

301

1618

(3011397) Hemoglobin [Presence] in Urine by Test strip

909

6614

1.52

23.46

4.8

3.4

0.00

0.29

—

(3012544) pH of Venous blood

352

2010

1.84

23.40

5.2

3.7

7.38

0.29

218

1124

(3019977) pH of Arterial blood

376

2198

1.80

23.14

6.1

8.9

7.42

0.68

228

1186

(3007930) Methemoglobin/Hemoglobin.total in Blood

171

751

2.35

23.09

4.8

5.9

0.86

0.90

0.65

161

706

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

192

888

2.24

22.95

1.3

—

(3022948) Iron [Moles/volume] in Serum or Plasma

620

4157

1.61

22.91

2.3

2.4

14.51

umol/l

0.00

578

3897

(3003396) Base excess in Arterial blood by calculation

371

2176

1.80

22.56

5.9

8.8

1.18

0.78

mmol/l

1.53

309

1764

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2844

26145

1.74

22.49

4.7

4.1

5.60

5.69

mmol/l

3.94

2729

24692

(3002173) Hemoglobin [Mass/volume] in Arterial blood

326

1845

1.85

22.26

6.3

9.8

124.87

122.71

g/l

1.20

315

1805

(3009445) Proteinase 3 Ab [Units/volume] in Serum

210

1022

2.13

22.10

1.9

1.6

23.62

13.90

iu/ml

—

(3045414) Leukocytes [Presence] in Urine

407

2492

1.72

21.26

2.0

0.05

0.01

estimate

0.49

577

(3002032) Base excess in Venous blood by calculation

336

1948

1.81

21.19

5.2

3.7

2.06

1.67

mmol/l

1.71

293

1694

(3004789) Transferrin [Mass/volume] in Serum or Plasma

569

3810

1.60

20.96

2.2

2.4

2.50

2.44

g/l

1.75

518

3535

(3004119) Hemoglobin [Mass/volume] in Venous blood

233

1208

2.00

20.66

5.4

3.1

133.97

131.34

g/l

1.18

227

1174

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

210

1052

2.07

20.47

1.4

1.3

34.13

37.02

u/ml

0.05

(3030981) Hyaline casts [#/volume] in Urine by Automated count

317

1828

1.81

20.32

3.2

2.3

0.17

0.36

e6/l

2.21

304

1722

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

2874

26644

1.72

20.13

14.5

10.9

91.85

90.69

ml/min/173m2

2.79

2708

24236

(3004588) Protein electrophoresis panel - Serum or Plasma

228

1185

1.99

20.07

2.2

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

7.31

19.92

1.2

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

609

4191

1.56

19.83

3.1

2.6

0.99

1.15

e6/l

0.39

340

2090

(3025159) Blasts/Leukocytes in Blood

379

2329

1.71

19.46

5.3

5.0

0.06

0.25

0.65

510

(3017732) Neutrophils [#/volume] in Blood

549

3707

1.58

19.38

2.9

3.0

4.11

4.53

e9/l

1.19

503

3343

(3014051) Protein [Presence] in Urine by Test strip

1127

8811

1.43

19.33

3.2

2.6

0.00

0.06

1.05

121

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

174

830

2.16

19.27

1.4

1.2

21.75

37.58

u/ml

1.18

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2757

25351

1.60

19.23

5.2

5.0

37.05

37.61

mmol/mol

3.31

2651

24235

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3118

29747

2.41

19.15

13.6

10.3

25.51

25.82

u/l

0.50

3075

29138

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

196

982

2.06

19.09

1.2

4.16

4.21

0.02

172

(3005322) IgE [Units/volume] in Serum or Plasma

391

2441

1.68

18.91

1.4

1.3

197.08

215.92

u/ml

0.10

357

2292

(3047181) Lactate [Moles/volume] in Blood

137

600

2.34

18.64

4.6

6.5

1.15

1.24

mmol/l

0.57

123

531

(3000060) B lymphocytes [#/volume] in Blood

102

4.46

18.46

2.3

2.0

0.05

0.17

e9/l

2.95

(3017181) Myelocytes/Leukocytes in Blood

379

2375

1.68

18.03

4.9

4.7

1.05

0.97

0.15

637

(3045424) Erythrocytes [Presence] in Urine

234

1286

1.88

17.45

2.1

2.0

0.01

0.02

estimate

0.17

459

(21494814) CD8 cells/Lymphocytes in Specimen

111

4.19

17.43

2.1

31.11

29.98

0.19

111

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

131

580

2.31

17.40

1.4

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

137

620

2.26

17.29

2.0

1.6

—

(3008898) HLA-B27 [Presence]

271

1564

1.80

17.27

1.1

—

(3042936) Bacteria identified in Isolate by Culture

510

3474

1.56

17.16

2.1

1.9

—

(3002179) Metamyelocytes/Leukocytes in Blood

363

2278

1.67

17.14

4.7

4.5

0.78

0.66

0.28

604

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

364

2287

1.67

17.11

3.5

3.6

4.50

4.57

pmol/l

0.89

330

2085

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

245

1385

1.83

16.71

2.3

2.0

3.64

7.22

ug/l

5.17

211

1237

(3007853) Bacteria identified in Skin by Aerobe culture

475

3210

1.56

16.51

1.9

1.6

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2373

21367

1.42

16.37

3.9

3.1

36.99

38.10

u/l

0.36

2284

20541

(3021440) Promyelocytes/Leukocytes in Blood

360

2285

1.65

16.24

5.0

4.8

0.12

0.13

0.06

547

(3022145) Colonoscopy Study observation

458

3083

1.57

16.18

1.3

1.4

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

308

2.74

16.00

1.5

1.4

6.07

6.51

g/l

0.53

229

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

5.39

15.88

1.0

1.1

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

499

3439

1.53

15.84

2.3

2.5

24.15

24.08

0.04

466

3203

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

439

2941

1.57

15.82

1.3

100.63

152.86

u/ml

2.75

180

1170

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

367

2361

1.63

15.67

3.3

4.4

216.78

235.15

u/l

2.57

347

2263

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

292

1771

1.71

15.63

3.4

3.3

1.22

1.23

mmol/l

1.11

261

1511

(3024139) IgG subclass 3 [Mass/volume] in Serum

307

2.71

15.55

1.5

1.4

0.35

0.38

g/l

0.42

226

(3028192) IgG subclass 2 [Mass/volume] in Serum

307

2.71

15.55

1.5

1.4

2.89

2.99

g/l

0.16

227

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

312

1933

1.68

15.43

1.5

1.4

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

4.50

15.40

1.4

1.3

155.75

123.45

nmol/l

0.44

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

268

1594

1.74

15.38

1.7

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

303

1867

1.69

15.29

7.0

8.3

1.23

1.26

mmol/l

0.22

296

1830

(4062490) Immunoglobulin typing, IgG

301

2.70

15.04

1.5

1.4

—

(3020951) Lymphocytes/Leukocytes in Cerebral spinal fluid

10.85

14.96

1.1

1.0

47.08

80.00

—

(3023511) Choriogonadotropin [Units/volume] in Urine

231

1330

1.79

14.82

1.6

1.3

—

(3006653) Thiamine [Moles/volume] in Blood

140

3.54

14.71

1.3

1.5

134.32

134.18

nmol/l

0.01

140

(36660697) Celiac disease serology panel - Serum

417

2808

1.56

14.63

1.2

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

539

3840

1.48

14.49

3.4

2.7

3.35

3.70

e6/l

0.35

270

1728

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

410

2.41

14.36

1.2

1.3

—

34.29

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

636

4692

1.44

14.25

1.8

1.6

—

(3033658) Prothrombin time (PT) actual/Normal

840

6524

1.39

14.01

4.0

3.7

96.92

95.73

0.87

813

6370

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

110

497

2.26

13.99

1.4

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

179

973

1.89

13.82

1.4

1.3

4.32

3.26

u/ml

0.26

(3039162) Centromere protein B Ab [Units/volume] in Serum

419

2.36

13.70

1.5

1.3

9.78

52.40

u/ml

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

112

515

2.22

13.66

1.6

1.7

0.62

0.71

g/l

0.51

413

(3023323) Follitropin [Units/volume] in Serum or Plasma

439

3044

1.51

13.41

1.5

1.4

26.06

24.52

iu/l

0.44

391

2607

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

256

2.73

13.36

1.1

1.2

—

1.41

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

178

978

1.87

13.30

1.5

1.3

6.14

7.65

u/ml

0.17

133

(3003458) Phosphate [Moles/volume] in Serum or Plasma

416

2860

1.52

13.22

4.7

5.8

1.04

mmol/l

0.18

390

2677

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

409

2.34

13.07

1.2

125.00

404.67

titre

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

148

772

1.96

12.93

1.4

1.3

2.13

3.21

u/ml

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

178

988

1.85

12.89

1.1

3.17

4.78

eliau/ml

0.29

159

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

4.86

12.84

1.0

1.1

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

127

631

2.05

12.72

1.5

1.6

—

(3002079) Sodium [Moles/time] in 24 hour Urine

130

3.42

12.60

1.3

129.55

160.19

mmol/24h

1.96

130

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

193

1115

1.78

12.26

6.9

11.6

16.90

16.15

3.68

183

1075

(3039000) Anion gap in Blood by calculation

383

2.33

12.25

5.5

8.6

10.79

11.47

mmol/l

1.16

346

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

209

1237

1.74

12.21

2.4

2.6

105.46

132.22

ng/l

0.47

188

1107

(3048929) Epstein Barr virus Ab [Presence] in Serum

226

1367

1.70

12.20

1.2

1.3

—

(3018572) Chloride [Moles/volume] in Blood

384

2.33

12.18

5.5

8.6

105.63

105.68

mmol/l

0.04

347

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

169

3.05

12.14

1.5

1.4

5.09

6.00

u/l

0.71

143

(40758558) Short blood count panel - Blood

1011

8238

1.33

12.02

5.9

6.0

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

167

3.03

11.75

2.9

2.8

46.26

45.31

0.15

(3009343) pH of Capillary blood

215

1298

1.70

11.70

3.2

3.3

7.41

7.42

0.78

183

1085

(3017446) Testosterone [Moles/volume] in Serum or Plasma

281

1820

1.60

11.60

2.6

2.2

12.13

11.88

nmol/l

0.18

258

1672

(3009214) Lutropin [Units/volume] in Serum or Plasma

219

1332

1.69

11.59

1.5

1.3

12.37

10.25

u/l

1.16

185

1087

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

219

1339

1.68

11.37

3.2

3.3

5.15

kpa

0.02

211

1298

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

192

1136

1.73

11.24

2.9

3.2

1.46

1.63

mmol/l

0.30

136

850

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

2664

24930

1.39

11.20

20.2

14.9

13.32

13.37

1.30

2647

24610

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

167

2.96

11.14

2.9

3.1

746.10

809.49

u/ml

0.10

167

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

200

1201

1.71

11.10

1.4

1.3

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

1094

9102

1.31

10.97

2.2

2.1

—

(3025941) Bacteria identified in Stool by Culture

280

1836

1.57

10.96

1.3

1.2

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

242

2.59

10.94

1.3

1.7

—

(3044640) Blood type and Crossmatch panel - Blood

1075

8927

1.31

10.92

2.4

2.1

—

(3026493) Urate [Moles/volume] in Serum or Plasma

830

6649

1.33

10.90

2.3

302.73

316.24

umol/l

4.53

758

6059

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

325

2207

1.53

10.88

3.5

2.7

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

200

1210

1.70

10.81

1.5

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2464

22816

1.34

10.80

4.3

3.6

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

493

3642

1.42

10.71

2.5

2.0

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

766

6083

1.34

10.63

2.4

2.2

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

114

584

1.99

10.55

1.9

190.70

199.33

pmol/l

0.33

109

549

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

462

2.11

10.52

1.4

1.5

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

132

714

1.88

10.41

1.5

1.3

317.76

304.77

ug/g

0.27

358

(3020961) Endomysium IgA Ab [Titer] in Serum

275

1822

1.56

10.29

1.2

1.1

104.00

113.92

titre

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

290

1954

1.53

10.06

1.7

1.6

304.25

293.43

mu/l

0.16

264

1757

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

359

2.23

10.01

1.4

1.5

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

138

769

1.83

9.92

1.4

1.3

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

294

1993

1.52

9.91

2.3

2.4

80.28

76.71

ml/min/173m2

1.08

124

832

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

252

1656

1.57

9.78

1.2

1.1

1.14

2.06

u/ml

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

113

596

1.93

9.64

1.5

1.6

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

151

2.87

9.32

1.2

1.1

—

(3035933) Granulocytes/Leukocytes in Blood

121

668

1.84

9.00

3.1

3.3

57.94

57.67

0.09

121

668

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

820

6713

1.30

8.92

2.5

2.3

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

377

2.12

8.90

1.3

0.14

0.49

nmol/l

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

140

811

1.76

8.88

1.5

1.4

18.86

24.23

u/l

1.45

119

677

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

214

2.50

8.79

1.2

1.05

ratio

0.04

174

(3010838) Calcium [Moles/time] in 24 hour Urine

481

1.98

8.78

2.0

2.1

4.82

5.17

mmol/24h

0.52

441

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

549

4261

1.35

8.70

1.7

1.8

1.38

0.01

490

3843

(3009508) Creatinine [Moles/volume] in Urine

959

8040

1.27

8.59

3.4

3.5

7.92

7.95

mmol/l

0.05

836

7055

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

136

2.89

8.58

1.2

1.1

—

(3012501) Base excess in Blood by calculation

427

2.02

8.38

3.6

3.3

2.10

2.36

mmol/l

0.45

265

(40761539) Cells [Type] in Urine sediment by Light microscopy

4.47

8.36

2.2

1.1

—

(3008295) Osmolality of Serum or Plasma

256

2.29

7.94

1.4

1.5

286.12

283.23

mosm/kgh2o

0.54

196

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

120

692

1.76

7.77

2.2

2.4

179.90

383.56

ug/l

1.39

108

642

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

100

547

1.85

7.71

1.3

1.2

8.72

3.49

u/ml

0.57

195

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

562

4450

1.32

7.70

2.7

2.1

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

313

2.13

7.61

1.3

0.17

0.23

nmol/l

0.47

234

(4034850) Laboratory test

133

795

1.70

7.59

8.5

7.6

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

904

7619

1.26

7.57

1.8

—

(3003327) Ova and parasites identified in Stool by Light microscopy

198

1311

1.54

7.47

2.0

1.7

—

(3007461) Platelets [#/volume] in Blood

3180

31226

2.24

7.42

27.6

18.9

264.43

263.19

e9/l

0.58

3162

30775

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

3.35

7.37

1.1

1.3

90.31

93.99

0.27

(42529406) Shigella sp [Presence] in Stool by Culture

134

810

1.68

7.35

1.2

1.1

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

103

579

1.80

7.29

2.5

5.8

1797.27

555.40

iu/ml

0.76

(3024731) MCV [Entitic mean volume] in Red Blood Cells

3180

31235

2.22

7.26

27.5

18.8

90.34

90.30

0.20

3172

31036

(3035941) MCH [Entitic mass]

3180

31236

2.21

7.25

27.5

18.8

30.15

30.12

0.61

3172

31037

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

3180

31237

2.21

7.23

27.9

19.2

40.54

41.06

1.19

3172

31019

(3026361) Erythrocytes [#/volume] in Blood

3180

31239

2.21

7.19

27.5

18.8

4.52

4.53

e12/l

0.21

3158

30728

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

438

1.92

7.16

1.1

0.39

1.08

—

(3011985) Renin [Units/volume] in Plasma

390

1.97

7.12

1.8

1.6

39.04

66.47

mu/l

0.97

352

(3010813) Leukocytes [#/volume] in Blood

3180

31244

2.20

7.10

27.6

18.9

6.61

6.68

e9/l

1.18

3157

30718

(3014765) Yersinia sp identified in Stool by Organism specific culture

132

803

1.67

7.08

1.2

1.1

—

(3023520) Reticulocytes [#/volume] in Blood

233

1615

1.48

7.08

2.0

2.9

69.33

72.10

e9/l

0.55

174

1141

(40761536) Microorganisms panel - Urine sediment

325

2397

1.40

7.05

5.3

3.4

—

(3000963) Hemoglobin [Mass/volume] in Blood

3180

31248

2.19

7.03

27.7

18.9

135.64

135.59

g/l

0.08

3172

31046

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

3.40

6.96

1.0

1.1

—

(3023419) Bacteria identified in Sputum by Culture

252

2.20

6.94

2.7

2.9

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

107

619

1.75

6.90

1.9

1.6

370.13

356.78

mu/l

0.16

499

(3049717) Cytology report of Urine Cyto stain

525

1.81

6.82

2.1

2.3

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

6.69

6.80

1.1

1.2

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

149

947

1.60

6.74

1.4

1.5

0.37

0.46

nmol/l

0.89

123

765

(3019225) pH of Specimen

282

2053

1.41

6.60

3.6

3.5

7.34

7.35

0.16

222

1494

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

100

575

1.76

6.60

3.1

2.8

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

128

788

1.65

6.58

1.1

1.2

—

45.51

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

320

2.02

6.48

1.7

1.4

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

115

693

1.68

6.43

2.1

1.9

0.60

1.89

ug/l

2.07

102

626

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

129

804

1.63

6.33

1.2

1.1

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

323

2.00

6.32

1.7

1.4

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

408

3173

1.33

6.30

2.3

2.7

5.91

6.72

umol/l

0.58

351

2754

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

5.95

6.29

1.1

1.0

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

172

1149

1.52

6.27

1.6

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

387

1.91

6.26

1.5

1.7

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

318

2.00

6.22

1.7

1.4

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

219

2.21

6.16

1.3

1.7

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

120

742

1.64

6.09

1.2

1.3

227.10

260.88

u/ml

0.87

480

(3027945) Reticulocytes/Erythrocytes in Blood

297

2215

1.38

6.03

2.3

2.8

1.63

1.76

1.78

274

1996

(3036489) Thrombin time

162

1079

1.53

6.00

2.3

2.0

21.68

20.57

0.58

125

927

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

870

7459

1.23

6.00

1.6

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

302

2.01

5.99

1.6

1.4

—

(3000494) Fungus identified in Specimen by Culture

438

3467

1.30

5.95

1.6

1.4

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

296

2.01

5.94

1.2

45.20

60.12

u/ml

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

305

1.99

5.84

1.6

1.4

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

232

1669

1.42

5.83

2.4

2.2

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

559

1.72

5.82

1.4

1.3

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

306

1.98

5.79

1.6

1.4

—

(3016879) Cocaine [Presence] in Urine

266

1965

1.39

5.73

2.3

2.2

—

(1616796) Gas panel - Central venous blood

458

1.79

5.70

3.9

2.9

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

175

2.30

5.69

1.2

1.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

444

1.80

5.68

1.2

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

778

6630

1.23

5.64

2.4

2.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

324

1.93

5.59

1.3

1.1

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

131

848

1.57

5.54

2.1

2.0

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

146

2.41

5.54

1.2

0.31

0.28

g/l

0.83

117

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

368

1.87

5.52

1.5

1.4

341.84

370.13

pmol/l

0.26

325

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

100

606

1.67

5.52

2.3

2.1

9.90

10.54

g/l

0.71

563

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

232

1687

1.40

5.49

2.9

3.8

60.50

76.48

ng/l

5.80

204

1515

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

400

1.82

5.39

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

400

1.82

5.39

1.3

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

408

1.81

5.36

1.8

1.6

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

287

1.97

5.35

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

224

1629

1.40

5.31

1.5

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

109

684

1.61

5.27

2.3

2.0

2.56

2.94

g/l

3.88

101

644

(40768804) Tissue Pathology biopsy report

1302

11711

1.19

5.25

2.1

2.0

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

112

709

1.60

5.22

2.3

2.0

3.56

3.72

g/l

0.51

104

669

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

112

710

1.60

5.20

2.3

2.0

6.95

7.32

g/l

1.84

104

670

(3000991) Gas panel - Venous blood

245

1820

1.37

5.12

9.1

9.5

—

(4268621) Lupus anticoagulant assay

379

1.81

5.06

2.4

2.3

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

111

710

1.58

4.98

2.3

2.0

4.24

4.31

g/l

0.48

103

669

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

246

1838

1.37

4.97

2.4

1.9

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

6.89

4.95

1.1

—

(3024869) Neuronal Ab [Presence] in Serum

5.02

4.93

1.1

—

(3037121) Protein [Mass/volume] in Urine

122

800

1.55

4.91

3.8

3.5

263.66

358.50

mg/l

0.51

360

(44790048) Parainfluenza type 2 nucleic acid detection

325

1.86

4.90

1.4

1.5

—

(44790047) Parainfluenza type 1 nucleic acid detection

325

1.86

4.90

1.4

1.5

—

(44790049) Parainfluenza type 3 nucleic acid detection

325

1.86

4.90

1.4

1.5

—

(44806118) Parainfluenza type 4 nucleic acid detection

325

1.86

4.90

1.4

1.5

—

(3004616) Nuclear Ab [Presence] in Serum

398

1.78

4.89

1.3

—

(3027008) Opiates [Presence] in Urine

279

2131

1.34

4.89

2.3

2.0

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

496

1.69

4.87

2.3

2.1

132.25

131.25

g/l

0.12

400

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.78

4.87

1.2

1.1

—

(3000764) Benzodiazepines [Presence] in Urine

277

2118

1.34

4.82

2.3

2.1

—

(3028707) Methadone [Presence] in Urine by Screen method

133

893

1.51

4.81

3.2

2.9

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2720

26195

1.24

4.79

4.0

3.7

1.25

1.24

mmol/l

0.15

2588

24900

(3013139) Helicobacter pylori Ag [Presence] in Stool

280

2148

1.33

4.76

1.3

1.2

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

484

1.69

4.76

4.3

3.2

22.61

23.02

mg/l

0.04

331

(3028300) Cannabinoids [Presence] in Urine

279

2140

1.33

4.75

2.3

2.1

—

(3042631) Mycobacterium sp identified in Specimen

230

2.01

4.75

1.9

2.6

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

3.42

4.74

1.1

0.61

0.70

umol/24h

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

110

711

1.57

4.73

1.2

1.1

7.50

14.14

au/ml

1.71

209

(3022313) Gas panel - Capillary blood

136

922

1.50

4.71

3.2

3.3

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

625

1.60

4.71

2.4

2.2

0.86

0.76

g/l

0.11

564

(3011288) Drugs identified in Urine by Screen method Nominal

207

1519

1.39

4.68

3.3

3.0

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

6.13

4.60

1.1

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

536

1.64

4.57

1.3

4.89

3.59

u/ml

0.26

229

(43055514) Macroprolactin [Presence] in Serum or Plasma

130

2.32

4.42

1.2

1.4

—

(3012516) Albumin [Mass/volume] in Urine

773

6725

1.20

4.40

3.3

3.5

25.41

50.80

mg/l

6.61

441

4246

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

132

904

1.48

4.37

4.0

2.6

3.22

3.56

g/l

3.28

122

863

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.66

4.36

1.0

1.2

—

(3027944) Amphetamines [Presence] in Urine

272

2107

1.32

4.34

2.2

2.1

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

125

2.33

4.33

1.1

96.87

94.94

0.16

(3004451) EKG impression Narrative

2.60

4.30

1.5

1.2

—

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

5.52

4.28

1.8

1.7

1.08

3.66

mg/l

—

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

5.52

4.28

1.8

1.7

5.75

5.41

mg/l

—

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

5.52

4.28

1.8

0.78

2.92

mg/l

—

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

5.52

4.28

1.8

1.7

2.56

3.84

mg/l

—

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

5.52

4.28

1.8

1.7

0.43

0.92

mg/l

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

197

1457

1.37

4.27

1.4

1.7

0.21

0.30

mg/l

1.79

673

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

157

1117

1.43

4.27

2.2

—

(3026389) Candida sp identified in Specimen by Organism specific culture

439

1.68

4.23

1.5

1.3

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

283

1.85

4.23

1.3

1.1

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

114

763

1.51

4.23

1.9

1.8

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

177

1289

1.39

4.22

1.6

1.7

6.52

11.69

u/ml

2.42

368

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

284

1.84

4.19

1.3

1.1

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

121

2.33

4.17

1.3

1.1

95.13

100.20

0.27

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

4.35

4.12

1.1

1.2

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

148

2.17

4.08

1.6

2.1

1.82

1.91

u/field

0.05

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

545

1.59

4.07

1.1

2.05

3.00

0.50

112

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

4.63

4.05

1.1

1.2

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

192

1429

1.37

4.02

8.8

9.0

24.92

24.84

mmol/l

0.12

192

1424

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

288

1.82

4.02

1.1

4.44

8.13

iu/ml

1.38

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

131

912

1.45

4.02

2.9

2.4

164.10

173.12

0.70

121

868

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

274

1.84

4.00

1.2

1.1

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

5.01

4.00

1.8

1.14

0.85

mg/l

—

(3020682) Albumin/Creatinine [Ratio] in Urine

776

6805

1.18

4.00

3.9

4.2

4.82

9.00

mg/mmol

3.74

453

4266

(40759836) Histone Ab [Presence] in Serum by Immunoblot

282

1.82

3.97

1.3

1.1

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

111

750

1.50

3.96

3.3

24.87

24.80

mmol/l

0.10

104

703

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

325

2611

1.27

3.95

2.9

2.4

32.94

55.44

u/l

0.66

281

2234

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

290

1.81

3.94

1.3

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

4.46

3.93

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

240

1.89

3.92

1.1

1.2

116.78

115.54

pmol/l

0.04

240

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

112

2.33

3.92

1.2

65.69

68.62

ug/l

0.11

112

(3047007) Chlamydophila sp Ab [Presence] in Serum

576

1.56

3.87

1.2

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

119

2.28

3.87

1.2

1.4

76.37

94.86

nmol/24h

0.58

119

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

197

1487

1.35

3.79

1.8

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

278

2204

1.29

3.76

2.4

0.23

0.22

g/l

0.86

263

2083

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

108

2.33

3.75

1.4

—

(3022621) pH of Urine by Test strip

294

2349

1.28

3.74

2.4

2.2

6.31

6.15

1.85

182

1449

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2859

27831

1.24

3.65

4.8

4.3

4.77

4.79

mmol/l

0.46

2746

26687

(3019832) Treponema pallidum Ab [Presence] in Serum

689

6026

1.18

3.63

1.9

1.8

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

260

2054

1.29

3.62

1.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.87

3.62

1.2

1.1

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

163

2.04

3.59

1.5

1.7

—

(3017569) Oxygen content in Arterial blood

2.40

3.55

2.6

2.8

16.74

16.98

0.13

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

141

1021

1.40

3.53

1.9

2.2

2.48

3.72

iu/l

4.53

465

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

192

1.94

3.52

1.4

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

192

1.94

3.52

1.4

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

192

1.94

3.52

1.4

1.5

—

(3018333) Ribosomal P Ab [Presence] in Serum

264

1.79

3.52

1.2

1.1

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

400

1.64

3.51

1.4

1.6

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

272

1.78

3.49

1.3

1.1

—

(4195642) Thrombophilia screening test

503

1.56

3.48

1.3

1.2

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

172

1.99

3.48

1.2

1.1

5.88

25.78

u/ml

—

(40768443) Skin Pathology biopsy report

153

1126

1.38

3.48

1.2

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

101

690

1.48

3.46

1.1

1.4

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

106

2.27

3.45

1.5

1.4

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

237

1.83

3.43

1.2

—

(4024509) Urine culture

153

1130

1.37

3.41

1.8

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

245

1.81

3.40

1.4

1.7

58.46

54.70

0.23

159

(3020779) Urea [Moles/volume] in Serum or Plasma

225

1760

1.30

3.40

5.2

7.9

6.35

7.81

mmol/l

4.40

216

1711

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

133

961

1.40

3.38

2.4

2.2

97.47

95.23

0.60

119

924

(3021879) Hepatitis B virus core Ab [Presence] in Serum

382

3183

1.23

3.38

1.6

1.5

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

231

1.83

3.37

1.0

1.2

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

647

1.48

3.32

1.5

1.8

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

4.36

3.30

2.0

2.1

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

148

2.04

3.30

1.0

1.1

87.04

91.23

0.42

115

(4094501) Cardiovascular stress test using bicycle ergometer

658

1.47

3.25

1.1

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2872

28027

1.22

3.22

5.2

4.7

2.85

2.86

mmol/l

0.07

2755

26791

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

442

3755

1.21

3.22

4.9

4.3

1.85

2.11

ug/l

0.27

410

3454

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

235

1.80

3.21

1.2

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

2.58

3.21

1.3

1.1

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

178

1.92

3.19

1.4

1.6

2.36

2.59

nmol/l

0.07

130

(3020191) Ethanol [Moles/volume] in Serum or Plasma

236

1.79

3.17

1.9

1.6

1.12

1.20

promille

0.13

192

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

2.47

3.12

1.3

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

2.47

3.12

1.3

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

2.47

3.12

1.3

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

2.47

3.12

1.3

1.1

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

131

2.07

3.12

1.3

1.6

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

112

799

1.42

3.09

2.1

2.3

4.44

5.12

umol/l

0.59

597

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

283

1.71

3.08

1.3

1.2

1.51

1.52

u/ml

0.00

143

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

186

1440

1.31

3.06

1.8

4.59

4.38

mg/l

0.06

150

1040

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

126

2.07

3.02

1.0

1.3

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

555

1.49

2.99

2.3

2.0

0.02

0.01

g/l

0.10

513

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

2.35

2.98

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

2.35

2.98

1.4

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2842

27743

1.20

2.95

4.7

4.2

1.48

1.49

mmol/l

0.65

2728

26493

(3003181) Sodium [Moles/volume] in Urine

302

1.67

2.95

1.3

1.5

75.26

65.26

mmol/l

0.68

255

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1250

11563

1.13

2.95

1.9

1.8

1.37

mmol/l

0.03

1102

10178

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

287

1.68

2.95

1.4

1.6

—

(3007566) Smooth muscle Ab [Titer] in Serum

123

901

1.38

2.93

1.2

1.3

182.00

118.13

titre

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.71

2.92

1.1

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

501

1.51

2.91

2.3

2.1

0.00

g/l

-0.00

481

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

108

2.14

2.90

1.1

—

(3033099) Centromere Ab [Titer] in Serum

2.38

2.89

1.0

1.2

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

136

1.99

2.85

1.3

1.6

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

150

1.94

2.84

1.4

1.6

—

(3044927) Protein electrophoresis panel - Urine

150

1.94

2.84

1.2

1.1

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

506

1.49

2.79

1.1

123.68

117.75

1.21

458

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

619

5477

1.16

2.78

1.7

1.5

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

354

2987

1.21

2.78

4.1

3.6

21.35

21.45

0.04

146

1143

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

110

2.10

2.78

1.4

1.7

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

110

2.10

2.78

1.4

1.7

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

110

2.10

2.78

1.4

1.7

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

110

2.10

2.78

1.4

1.7

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

648

1.43

2.76

1.2

1.4

143.42

150.97

au/ml

0.20

178

(3025018) Bordetella pertussis Ab [Titer] in Serum

279

1.66

2.70

1.1

1.2

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

296

1.63

2.65

1.6

1.7

—

(1002224) Polysomnography panel

227

1839

1.25

2.64

1.2

1.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

513

1.47

2.63

1.3

1.1

14.65

18898.65

iu/ml

0.56

128

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

2.93

2.61

1.3

1.0

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

4.67

2.59

2.3

5.7

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

107

2.06

2.57

1.0

1.3

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

219

1774

1.25

2.56

1.4

1.3

198.64

232.47

miu/ml

0.78

107

912

(3037756) Immunofixation for Serum or Plasma

315

1.60

2.55

1.6

1.5

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

527

1.45

2.50

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

103

2.05

2.41

1.0

35.52

36.01

iu/ml

0.01

103

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

6.26

2.37

1.2

1.0

—

(3052851) Hemolysis interference index of Serum or Plasma

652

1.39

2.35

3.1

2.6

1.97

2.00

index

0.02

347

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

145

1845

0.78

2.35

1.5

1.15

ratio

0.00

1105

(3023183) Ammonium ion [Moles/volume] in Plasma

427

1.48

2.35

2.5

2.9

33.44

33.86

umol/l

0.04

402

(3028433) Virus identified in Specimen by Culture

2.26

2.34

1.2

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

323

1.56

2.32

1.1

17.82

15.02

u/ml

0.34

157

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

146

1849

0.78

2.28

1.5

0.99

0.95

ratio

0.37

1109

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

146

1849

0.78

2.28

1.5

1.09

1.20

ratio

0.95

1115

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

538

1.42

2.27

2.4

2.0

0.01

0.00

g/l

0.49

482

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

144

1823

0.78

2.25

1.4

1.5

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

224

1.66

2.24

1.6

2.0

23.50

23.80

mg/l

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

123

945

1.31

2.22

1.2

1.1

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

441

1.46

2.21

3.8

3.2

1.28

3.14

ratio

1.31

235

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.69

2.20

1.0

1.1

0.04

0.02

u/ml

0.51

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

2.51

2.18

1.1

1.3

411.14

331.31

pmol/l

—

(3032773) Endomysium IgG Ab [Titer] in Serum

361

1.50

2.17

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

577

1.40

2.17

1.1

1.43

3.34

eliau/ml

2.64

306

(3040151) Glucose [Moles/volume] in Capillary blood

235

1.62

2.13

3.4

5.7

6.33

7.04

mmol/l

0.82

202

(3034860) Kappa light chains.free [Mass/volume] in Serum

505

1.42

2.09

4.0

3.3

24.43

62.89

mg/l

2.03

429

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

138

1.82

2.09

3.2

2.8

99.89

195.00

umol/l

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

123

1568

0.78

2.06

1.5

1.6

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

3.51

2.05

1.0

1.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

324

2795

1.18

2.04

4.2

4.0

32.17

31.85

0.22

248

2044

(3004716) Salmonella sp identified in Stool by Organism specific culture

229

1915

1.21

2.03

1.4

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

120

1529

0.78

2.01

1.4

1.5

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

185

1.68

2.00

1.3

1.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

161

1981

0.80

2.00

1.5

60.90

59.67

ug/l

0.11

131

1650

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

360

1.48

2.00

5.0

4.8

143.91

106.02

u/ml

0.20

113

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

110

848

1.31

1.97

1.8

2.0

1.51

1.41

g/l

0.51

751

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

4.55

1.94

1.0

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

505

1.39

1.93

4.1

3.3

26.02

42.00

mg/l

1.36

431

(3005033) Fetal Nuchal fold Thickness US

119

1504

0.78

1.88

1.4

1.5

1.24

1.26

0.11

1082

(3037692) Legionella sp identified in Specimen by Organism specific culture

2.16

1.88

1.0

1.5

—

(3028717) Thiamine [Mass/volume] in Blood

2.31

1.87

1.4

1.3

56.50

66.37

ug/l

1.27

(3009466) Valproate [Moles/volume] in Serum or Plasma

374

1.45

1.87

4.9

6.4

341.31

379.88

umol/l

1.11

339

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

2.65

1.86

1.8

1.9

—

(3002256) Pathology report gross observation

414

3669

1.15

1.84

1.2

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

3.53

1.83

1.0

1.1

—

0.07

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

160

1.69

1.81

2.7

3.9

8.57

8.71

mg/l

0.04

133

(44813793) Dust mix specific IgE antibody measurement

262

1.53

1.81

1.1

1.0

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

145

1.73

1.81

2.2

3.0

146.81

51.04

au/ml

—

(21494755) Public health laboratory ask at order entry panel

377

4259

0.87

1.80

1.3

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

378

1.44

1.78

1.2

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

192

1.62

1.77

1.4

1.2

—

(3017509) Phencyclidine [Presence] in Urine

2.35

1.77

1.5

1.2

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

591

1.35

1.77

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

617

1.34

1.77

1.1

1.2

—

(21494890) Protein electrophoresis panel - 24 hour Urine

163

1.66

1.71

1.8

1.9

—

(1761482) Bacteria [#/volume] in Urine by Culture

432

1.40

1.71

3.9

3.5

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

164

1.65

1.68

1.3

1.7

—

(44806420) Estimation of glomerular filtration rate

434

1.39

1.67

2.4

2.2

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

3.16

1.66

1.2

1.1

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

2.80

1.65

2.1

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

2.03

1.64

1.1

6.88

6.89

u/ml

0.00

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.44

1.64

2.1

2.5

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

229

1.53

1.62

1.8

2.3

33.66

32.18

1.67

229

(3022475) Manganese [Moles/volume] in Blood

3.58

1.61

1.0

1.4

0.15

umol/l

—

(3017704) Immunofixation for Urine

1.95

1.59

1.8

1.5

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

304

1.45

1.58

1.8

2.9

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

380

1.40

1.57

1.4

1.6

—

(3042517) Benzodiazepines panel - Urine

2.20

1.57

6.5

2.2

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.20

1.57

1.4

1.3

—

(3000330) Specific gravity of Urine by Test strip

139

1140

1.23

1.56

3.2

2.8

1.02

ratio

1.15

123

1004

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

382

1.39

1.53

1.2

1.1

101.83

97.21

0.94

355

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

194

1649

1.19

1.51

1.7

1.6

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

487

1.34

1.49

2.5

3.5

0.33

iu/ml

0.06

246

(4211845) Urine protein measurement

124

1.70

1.47

3.0

2.6

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

2.50

1.45

1.0

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

236

1.49

1.44

1.5

1.3

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

216

1863

1.17

1.43

2.1

2.7

21.01

49.71

u/ml

3.54

204

1807

(3006462) Nitrate [Presence] in Urine

110

1.73

1.42

3.2

2.7

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

137

0.44

1.40

1.0

1.1

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

2.42

1.39

1.4

1.2

—

(3005011) Chlamydia sp Ab [Titer] in Serum

2.08

1.38

1.8

1.3

—

(3051101) Glucose [Moles/volume] in Cord blood

2.61

1.36

3.3

5.0

8.93

7.24

mmol/l

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

800

1.25

1.31

4.0

3.7

1.17

1.31

mg/l

1.63

752

(3044242) Glucose [Moles/volume] in Arterial blood

106

1.70

1.29

3.2

2.5

8.30

8.12

mmol/l

0.06

106

(3032057) Clostridioides difficile [Presence] in Stool

2.36

1.29

1.9

2.1

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

2.78

1.28

1.0

—

(3000475) Leukocytes [#/volume] in Synovial fluid

553

1.29

1.28

1.6

1.7

16809.61

9182.59

e6/l

0.49

382

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

1.94

1.27

2.7

5.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

1.79

1.27

1.5

1.9

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

1.79

1.27

1.5

1.9

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

1.79

1.27

1.5

1.9

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

581

1.28

1.26

1.1

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

2.40

1.24

2.3

3.2

—

(3003694) ABO and Rh group [Type] in Blood

1021

9685

1.08

1.24

1.8

1.7

—

(3044941) Cell count panel - Synovial fluid

407

1.33

1.23

1.5

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

435

4753

0.90

1.23

1.9

1.8

3.50

3.43

ratio

0.53

337

3508

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

592

1.27

1.23

1.3

1.5

—

(21494434) Karyotype in Bone marrow

163

1.54

1.23

1.2

1.3

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

254

1.42

1.22

1.3

1.6

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

2.63

1.21

1.0

1.1

0.04

u/ml

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

2.63

1.21

1.2

1.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

2.16

1.21

1.0

—

(3008536) Aspergillus sp Ab [Presence] in Serum

2.16

1.21

1.3

2.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

246

1.43

1.21

1.1

1.0

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

213

1.46

1.20

3.3

—

(3051611) Lipemic interference index of Serum or Plasma

197

1.48

1.19

4.7

2.8

22.82

14.52

index

1.04

128

(3020356) Listeria sp identified in Specimen by Organism specific culture

2.11

1.18

1.1

1.2

—

(21491868) Cryoglobulin [Mass/volume] in Serum

117

1.63

1.18

1.0

1.1

—

0.06

g/l

—

(3035880) pH of Pleural fluid

1.88

1.18

1.0

1.2

7.47

7.39

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

437

1.31

1.17

1.1

1.42

1.46

g/l

0.38

402

(4198724) Urine methamphetamine measurement

190

1.48

1.16

3.5

3.3

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.34

1.12

1.1

1.2

1.37

1.69

umol/24h

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.38

1.09

1.0

1.2

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

2.38

1.09

5.2

1.6

280.80

349.90

umol/24h

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

160

1.50

1.09

1.5

1.1

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

144

1.53

1.08

1.1

1.4

34489.00

73083.29

e6/l

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

177

1.47

1.07

1.6

24.92

36.60

0.83

109

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

2580

25375

1.08

1.07

21.6

15.2

333.01

332.66

g/l

1.27

2570

25242

(3003740) Influenza virus B Ag [Presence] in Specimen

100

831

1.21

1.07

1.1

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

946

0.81

1.06

1.3

1.2

—

(3002523) Influenza virus A Ag [Presence] in Specimen

100

832

1.21

1.06

1.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

2.12

1.05

2.1

1.8

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

332

1.33

1.03

1.4

1.5

7.35

7.85

mmol/l

0.32

325

(3017817) Protein [Mass] in Urine collected for unspecified duration

187

1.45

1.03

2.1

3.1

706.44

1348.78

1.49

187

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

187

1.45

1.03

2.2

2.5

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

203

0.59

1.03

1.5

4.78

5.38

mmol/l

2.62

197

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

196

1.43

1.02

7.2

7.6

3.69

100.81

ug/l

0.60

127

(3023199) Leukocytes [#/volume] in Pleural fluid

163

1.48

1.01

1.2

1.4

2514.13

2216.07

e6/l

0.14

105

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

205

1.42

1.00

1.0

1.3

1314.29

1022.22

titre

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.88

1.00

1.3

1.2

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

156

1.48

0.98

1.0

11.37

11.31

u/ml

0.00

108

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

549

1.24

0.97

1.5

2.5

0.97

0.88

nmol/l

0.47

484

(3006922) Hepatitis E virus Ab [Presence] in Serum

275

1.35

0.97

1.1

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.85

0.96

1.1

1.3

—

(40765096) Chromosome analysis panel by Banding

1.74

0.96

1.0

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

247

0.65

0.96

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

339

1.30

0.92

1.2

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

2.14

0.91

2.3

3.8

40.17

43.22

umol/l

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

322

1.31

0.91

1.2

1.4

—

titre

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

183

0.60

0.91

1.5

1.3

—

(3020650) Glucose [Presence] in Urine

110

1.55

0.90

1.7

1.6

0.00

estimate

-0.00

110

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

190

1695

1.13

0.87

1.5

—

(3019174) dRVVT (LA screen)

2.00

0.87

1.3

1.1

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

136

1.47

0.86

9.2

8.6

1965.00

115.05

u/ml

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

170

1.41

0.85

2.7

3.8

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

251

0.68

0.84

13.1

16.8

531.47

5968.73

nmol/l

0.54

243

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

202

0.64

0.82

1.2

1.5

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

335

3625

0.92

0.82

1.6

3.57

3.48

mmol/l

0.87

238

2413

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

310

1.29

0.82

1.0

1.1

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.53

0.78

1.4

1.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.62

0.78

1.3

1.5

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

358

1.26

0.77

1.4

1.3

20.21

28.60

u/l

0.32

306

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

252

2304

1.10

0.77

2.8

0.60

0.71

ug/l

1.85

140

1245

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

115

1.48

0.76

1.2

1.1

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

1.77

0.76

1.2

1.9

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

116

1.47

0.74

1.3

2.0

50.26

98.93

ng/l

4.80

116

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

236

1.32

0.74

1.0

1.3

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

2.00

0.72

1.0

—

(3000093) Morphology [Interpretation] in Blood Narrative

202

1.34

0.72

1.1

—

(3047189) Immunofixation for 24 hour Urine

1.58

0.71

2.0

1.5

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

101

1.49

0.70

1.1

—

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

1.71

0.70

1.7

—

(3035320) C reactive protein [Mass/volume] in Body fluid

221

1.32

0.69

2.9

2.3

28.88

28.84

mg/l

0.00

150

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

1.85

0.68

1.0

1.2

—

22.50

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

1.85

0.68

1.0

1.2

—

21.67

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

100

874

1.15

0.67

1.4

51.77

108.54

pmol/l

2.31

855

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

1.63

0.66

1.0

1.1

1.40

1.22

mom

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

260

0.73

0.66

19.7

21.7

894.58

1448.36

nmol/l

2.72

253

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.61

0.65

1.4

—

0.29

—

(40768441) Liver Pathology biopsy report

213

0.70

0.64

1.2

1.5

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

1.73

0.64

4.8

8.7

22.40

25.28

ug/min

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

143

1285

1.12

0.63

1.5

54.43

60.26

ug/l

1.28

143

1285

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

155

1.36

0.63

1.6

1.4

137.53

215.18

pmol/l

0.65

155

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.67

0.61

1.0

2.0

—

(3044009) aPTT.lupus sensitive (LA screen)

1.67

0.61

1.4

1.2

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

0.60

0.0

1.5

—

38.71

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.60

0.0

1.3

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

0.00

0.58

0.0

1.0

—

25.78

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

123

1.38

0.57

1.1

1.3

—

1280.00

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

1.72

0.57

1.3

2.6

4.13

3.15

mg/l

—

(3025130) Human papilloma virus identified in Specimen

827

0.87

0.56

1.8

1.9

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

321

1.22

0.54

1.9

1.7

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

1.47

0.54

2.8

3.4

0.96

1.33

0.59

(3026250) Tacrolimus [Mass/volume] in Blood

133

0.68

0.51

43.8

42.3

7.30

7.29

ug/l

—

122

(3008401) Mugwort IgE Ab [Units/volume] in Serum

891

0.88

0.49

1.1

0.33

1.07

u/ml

1.98

396

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.56

0.49

1.4

1.1

1.21

1.19

mmol/l

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

137

1.32

0.47

1.0

1.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

152

1650

0.92

0.47

1.1

0.69

0.64

ratio

0.32

167

(3012441) Differential panel - Pleural fluid

146

1.30

0.47

1.2

1.4

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

1.47

0.47

2.1

1.7

44.54

41.86

g/l

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

227

1.24

0.46

1.7

1.9

5.45

1.66

u/ml

—

(3022689) Creatine [Moles/volume] in Urine

0.62

0.45

1.0

1.5

8.36

9.40

mmol/l

—

(3043410) Blood group antigens tested for on Red Blood Cells

0.62

0.45

1.4

1.2

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

283

1.20

0.45

1.1

—

(44806071) Cardiolipin IgM antibody measurement

1.37

0.44

1.0

1.1

—

(3001556) Androgen free Index in Serum or Plasma

1.37

0.44

1.0

1.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

131

1.30

0.42

1.1

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

1.43

0.41

1.1

1.2

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.36

0.41

1.5

2.1

11.48

16.00

umol/l

1.05

(4212803) Bone marrow aspirate examination

0.00

0.41

0.0

1.0

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

0.00

0.40

0.0

8.7

—

149.20

—

(4015189) Microbial culture of sputum

1.47

0.40

1.4

3.6

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.47

0.40

1.0

—

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

0.00

0.40

0.0

1.3

—

8.92

—

(3010937) Rubella virus Ab [Presence] in Serum

1.39

0.38

1.0

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.32

0.37

1.0

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.32

0.37

1.0

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.32

0.37

1.0

1.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

673

0.89

0.37

1.0

1.1

0.83

0.23

u/ml

0.37

207

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

694

0.89

0.37

1.3

1.2

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

1.36

0.36

1.1

1.3

—

(40768793) Breast Pathology biopsy report

823

1.10

0.35

1.4

1.3

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

126

1353

0.93

0.34

1.5

1.4

—

(3045142) Bone marrow Pathology biopsy report

237

1.18

0.33

1.2

1.4

—

(3020876) Protein [Mass/time] in 24 hour Urine

238

1.18

0.32

2.5

2.3

1.13

1.25

g/24h

0.11

146

(3001686) Cold agglutinin [Titer] in Serum or Plasma

1.28

0.32

1.2

1.3

—

221.60

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

1.33

0.32

3.0

2.2

—

(3039443) Prostate specific Ag panel - Serum or Plasma

326

0.86

0.31

1.4

1.6

—

(40765089) Chromosome analysis panel - Blood by G-banded

164

0.79

0.30

1.1

1.0

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

240

1.17

0.30

1.1

1.3

—

250.00

—

(40768795) Lymph node Pathology biopsy report

249

0.84

0.29

1.1

1.2

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.32

0.28

1.4

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.28

0.28

2.2

1.6

10.38

8.24

ug/l

1.06

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

261

1.15

0.27

1.3

1.7

—

(3000012) Reticulocyte production index

233

1.16

0.27

1.8

2.2

1.05

0.86

0.69

138

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.23

0.27

6.5

4.2

5.27

4.72

kpa

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.23

0.27

6.5

4.2

10.62

11.05

kpa

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

452

1.11

0.26

1.8

1.5

—

(3002619) Bacteria identified in Specimen by Culture

1.25

0.25

1.3

1.2

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

892

0.93

0.25

1.1

1.12

1.56

u/ml

0.45

445

(3041806) Other cells [#/volume] in Blood by Manual count

213

0.84

0.25

1.8

1.6

0.50

0.48

e9/l

0.12

213

(3023430) Cat dander IgE Ab [Units/volume] in Serum

735

0.92

0.24

1.1

3.11

4.32

u/ml

0.45

329

(3045788) Cell count panel - Pleural fluid

133

1.20

0.24

1.2

1.4

—

(3011897) Casein IgE Ab [Units/volume] in Serum

1.28

0.24

1.3

1.2

0.01

0.23

u/ml

—

(3000285) Sodium [Moles/volume] in Blood

1.32

0.23

1.0

1.1

137.20

138.90

mmol/l

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.22

0.22

8.4

6.6

10.88

5.06

kpa

—

(1761868) Lipid panel - Serum or Plasma

1359

13434

1.02

0.22

2.8

2.6

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

1.1

—

(3034614) HLA Ag [Interpretation]

0.00

0.21

0.0

1.1

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.21

0.0

2.0

—

(3025296) Carrot IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

5.89

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.21

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.21

0.0

2.0

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

0.00

0.21

0.0

1.4

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.21

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.21

0.0

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3009208) Meadow Fescue IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

21.27

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

220

0.86

0.21

1.1

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.21

0.0

1.2

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

0.21

0.0

1.2

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.00

0.21

0.0

2.8

—

(3001729) Color of Synovial fluid

0.00

0.21

0.0

1.9

—

(40758358) Immune stain study

0.00

0.20

0.0

1.0

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

222

1.13

0.19

1.1

1.2

12.80

8.59

mm/h

0.71

222

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

1.17

0.17

3.6

1.7

13.20

54.25

u/l

—

(4146454) Self-monitoring of blood glucose

174

0.86

0.17

2.9

2.8

—

(3001019) Free T4 and TSH panel - Serum or Plasma

239

2462

0.97

0.17

1.6

1.7

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

937

0.95

0.17

1.1

5.63

5.79

u/ml

0.04

531

(3050129) First trimester maternal screen panel - Serum or Plasma

235

2281

1.03

0.17

1.5

1.4

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

944

0.95

0.15

1.5

1.3

4.54

3.88

ug/l

0.18

874

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

107

1025

1.05

0.15

1.3

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.11

0.15

1.7

1.5

—

(4133840) Spirometry

0.81

0.14

1.1

1.2

—

(3024932) HLA-DR beta [Type]

0.80

0.14

1.0

1.1

—

(4281824) Cell count and differential, peritoneal fluid

295

1.09

0.14

1.2

1.1

—

(40768806) Pleura Pathology biopsy report

142

1.13

0.12

1.6

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

580

0.95

0.12

1.3

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

179

0.89

0.12

1.3

1.7

—

1051098.50

—

(3029396) Erythrocyte agglutination [Presence] in Blood

189

0.90

0.12

2.9

3.2

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

230

1.09

0.11

1.7

1.4

1.29

1.43

nmol/l

0.40

212

(3034426) Prothrombin time (PT)

105

1.14

0.11

1.2

29.00

28.49

0.12

105

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

144

1.11

0.10

1.2

1.5

13.81

5.47

u/l

—

120

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

109

1057

1.03

0.10

1.2

1.1

1.55

2.40

u/ml

0.80

561

(4035726) Immunohistochemistry procedure

203

2073

0.98

0.10

1.3

1.4

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

310

1.07

0.10

1.1

1.0

0.37

0.64

u/ml

0.58

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

812

1.04

0.09

1.7

1.6

—

(40758292) HTLV I+II Ab panel - Serum

1.03

0.08

1.3

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.83

0.07

4.7

3.0

40.33

44.26

—

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

0.83

0.07

9.0

6.0

10.50

8.17

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

186

1.08

0.07

1.6

1.9

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

0.87

0.07

3.3

2.9

0.63

0.62

mmol/l

—

(3024471) HLA-A [Type]

1.03

0.07

1.0

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

415

0.96

0.05

1.2

1.4

34.59

36.47

nmol/l

0.11

374

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

149

1.07

0.05

1.8

1.6

—

(3020874) Milk IgE Ab [Units/volume] in Serum

307

1.04

0.05

1.1

0.39

2.23

u/ml

0.93

(40768446) Kidney Pathology biopsy report

110

1.09

0.05

1.1

1.6

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

190

1.05

0.04

1.4

45359.00

85962.84

e6/l

—

126

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

350

3480

1.01

0.03

1.6

1123.31

1008.09

mu/l

1.02

291

2924

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

122

1.07

0.02

1.0

1.2

—

(3000034) Microalbumin [Mass/volume] in Urine

172

1.05

0.02

2.8

3.2

123.00

37.10

mg/l

0.41

124

(3014133) Dog dander IgE Ab [Units/volume] in Serum

780

0.99

0.02

1.1

5.81

3.73

u/ml

0.41

386

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

196

1972

0.99

0.02

3.3

4.5

4.47

33.80

ug/l

0.98

143

1500

(3016750) Collection duration of Urine

106

0.94

0.01

1.8

2.6

495.50

512.87

min

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

184

1.03

0.00

1.3

67.26

73.60

umol/l

0.80

184

(37208534) Antinuclear antibody arbitrary concentration in serum

111

0.99

0.00

1.1

1.0

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

289

1.00

0.00

1.1

1.0

0.10

1.47

u/ml

0.58

(3024263) Appearance of Synovial fluid

104

0.96

0.00

1.5

2.2

—

(40768800) Prostate Pathology biopsy report

188

1.01

0.00

1.2

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

722

1.00

0.00

2.7

3.8

933.11

519.33

u/ml

0.25

616

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

433

0.99

0.00

2.7

2.6

57.88

99.30

ug/min

0.57

271

(3012494) Peanut IgE Ab [Units/volume] in Serum

127

1.02

0.00

1.1

0.26

10.02

u/ml

—

(3033086) Enterovirus Ab [Titer] in Serum

0.00

0.0

1.0

—

(3041184) Isoniazid [Presence] in Urine

0.00

-0.00

0.0

1.5

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

0.00

-0.00

0.0

1.0

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

2.0

—

0.48

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

0.92

-0.00

1.1

1.8

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

0.92

-0.00

1.1

1.8

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

0.02

—

(3044007) Cell count panel - Peritoneal fluid

0.85

-0.00

1.6

2.0

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

0.96

-0.00

1.2

1.0

0.29

0.91

u/ml

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.00

-0.00

0.0

14.0

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

-0.00

0.0

1.4

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

2561.20

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

-0.00

0.0

1.0

—

(3018910) Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

54.06

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

5.3

—

0.22

—

(3014271) Vancomycin [Susceptibility]

0.98

-0.00

2.2

2.3

—

(3047185) IgG [Mass/volume] in Urine

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint G6_POSTOPNEURO and mortality.

Females

Parameter	HR [95% CI]	p-value
G6_POSTOPNEURO	1.074 [0.92, 1.25]	0.355
Birth year	0.993 [0.98, 1.0]	0.098

During the follow-up period (1.1.1998 — 31.12.2019), 273 out of 10559 females with G6_POSTOPNEURO died.

Males

Parameter	HR [95% CI]	p-value
G6_POSTOPNEURO	1.037 [0.9, 1.2]	0.615
Birth year	0.99 [0.98, 1.0]	0.029

During the follow-up period (1.1.1998 — 31.12.2019), 240 out of 4412 males with G6_POSTOPNEURO died.

Mortality risk

Mortality risk for people of age

years, who have G6_POSTOPNEURO.

N-year risk	Females	Males
1	0.117%	0.219%
5	0.627%	1.243%
10	1.585%	3.256%
15	2.824%	6.215%
20	4.87%	10.678%

Relationships between endpoints

↥

Index endpoint: G6_POSTOPNEURO – Postprocedural disorders of nervous system

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Postprocedural disorders of nervous system

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints